Details of the Drug Combinations

General Information of This Drug (ID: DM62QTW)

Drug Name
RTB101   DM62QTW
Indication
Disease Entry ICD 11 Status REF
Respiratory tract infection CA45 Phase 3 [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [2]
Drug Type
Small molecular drug

List of Combinatorial Drugs (CBD) Containing This Drug

947 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Abexinostat + RTB101 DCCE1ZT Abexinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
BMS-754807 + RTB101 DC2HAYL BMS-754807 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Bortezomib + RTB101 DC0L8U7 Bortezomib Adenocarcinoma (Cell Line: CAOV3) [3]
Bortezomib + RTB101 DCBK8GA Bortezomib Adenocarcinoma (Cell Line: OVCAR3) [3]
Bortezomib + RTB101 DCSFTSC Bortezomib Adenocarcinoma (Cell Line: A427) [3]
Bortezomib + RTB101 DCLY76B Bortezomib Adenocarcinoma (Cell Line: NCIH2122) [3]
Bortezomib + RTB101 DC2L65Q Bortezomib Adenocarcinoma (Cell Line: NCIH23) [3]
Bortezomib + RTB101 DCPLSK1 Bortezomib Adenocarcinoma (Cell Line: NCIH520) [3]
Bortezomib + RTB101 DCNM42Y Bortezomib Adenocarcinoma (Cell Line: COLO320DM) [3]
Bortezomib + RTB101 DCAQPN8 Bortezomib Adenocarcinoma (Cell Line: DLD1) [3]
Bortezomib + RTB101 DCQPRDL Bortezomib Adenocarcinoma (Cell Line: HCT116) [3]
Bortezomib + RTB101 DCIAOKW Bortezomib Adenocarcinoma (Cell Line: HT29) [3]
Bortezomib + RTB101 DC3G3GI Bortezomib Adenocarcinoma (Cell Line: SW-620) [3]
Bortezomib + RTB101 DCT1GE7 Bortezomib Amelanotic melanoma (Cell Line: A2058) [3]
Bortezomib + RTB101 DCYDPE0 Bortezomib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Bortezomib + RTB101 DCVWF3Q Bortezomib Germ cell tumour (Cell Line: PA1) [3]
Bortezomib + RTB101 DCFFVJJ Bortezomib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Bortezomib + RTB101 DCJNC0Q Bortezomib Malignant melanoma (Cell Line: A375) [3]
Bortezomib + RTB101 DCY31ZI Bortezomib Malignant melanoma (Cell Line: HT144) [3]
Bortezomib + RTB101 DCIT67R Bortezomib Malignant melanoma (Cell Line: RPMI7951) [3]
Bortezomib + RTB101 DC2CZ8K Bortezomib Malignant melanoma (Cell Line: SKMEL30) [3]
Bortezomib + RTB101 DCW0A6Z Bortezomib Malignant melanoma (Cell Line: UACC62) [3]
Bortezomib + RTB101 DCSZE8Y Bortezomib Mesothelioma (Cell Line: MSTO) [3]
Bortezomib + RTB101 DCJL801 Bortezomib Non small cell carcinoma (Cell Line: SKMES1) [3]
Bortezomib + RTB101 DCI62GE Bortezomib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Bortezomib + RTB101 DC04K35 Bortezomib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Bortezomib + RTB101 DC01W81 Bortezomib Prostate carcinoma (Cell Line: LNCAP) [3]
Bortezomib + RTB101 DCDWELD Bortezomib Prostate carcinoma (Cell Line: VCAP) [3]
Bortezomib + RTB101 DC60SB8 Bortezomib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Bortezomib + RTB101 DCVG3CX Bortezomib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Bortezomib + RTB101 DCUOTZ1 Bortezomib Breast carcinoma (Cell Line: ZR751) [4]
Bortezomib + RTB101 DCAHAV2 Bortezomib Breast carcinoma (Cell Line: KPL1) [4]
Bortezomib + RTB101 DCNBMYM Bortezomib Breast carcinoma (Cell Line: OCUBM) [4]
Bortezomib + RTB101 DC4KIQ9 Bortezomib Carcinoma (Cell Line: OV90) [4]
Bortezomib + RTB101 DC5RG3Q Bortezomib Carcinoma (Cell Line: EFM192B) [4]
Bortezomib + RTB101 DC7M6BR Bortezomib Carcinoma (Cell Line: MDAMB436) [4]
Bortezomib + RTB101 DCXXIF4 Bortezomib Colon adenocarcinoma (Cell Line: LOVO) [4]
Bortezomib + RTB101 DC3U8LH Bortezomib Colon carcinoma (Cell Line: RKO) [4]
Bortezomib + RTB101 DCOQ701 Bortezomib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bortezomib + RTB101 DCWEEOM Bortezomib Rectal adenocarcinoma (Cell Line: SW837) [4]
CA4P + RTB101 DCRLOPH CA4P Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
CF102 + RTB101 DCMFQ1N CF102 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Citarinostat + RTB101 DC0Y9SM Citarinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Dasatinib + RTB101 DCOLGRM Dasatinib Adenocarcinoma (Cell Line: CAOV3) [3]
Dasatinib + RTB101 DCSN06J Dasatinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Dasatinib + RTB101 DCZQMC8 Dasatinib Adenocarcinoma (Cell Line: A427) [3]
Dasatinib + RTB101 DC9CHXG Dasatinib Adenocarcinoma (Cell Line: NCIH1650) [3]
Dasatinib + RTB101 DC04LIT Dasatinib Adenocarcinoma (Cell Line: NCIH23) [3]
Dasatinib + RTB101 DC6XV2C Dasatinib Adenocarcinoma (Cell Line: NCIH520) [3]
Dasatinib + RTB101 DCQEUPS Dasatinib Adenocarcinoma (Cell Line: DLD1) [3]
Dasatinib + RTB101 DCRXVQ6 Dasatinib Adenocarcinoma (Cell Line: HT29) [3]
Dasatinib + RTB101 DCN5S4P Dasatinib Amelanotic melanoma (Cell Line: A2058) [3]
Dasatinib + RTB101 DCAMJ71 Dasatinib Germ cell tumour (Cell Line: PA1) [3]
Dasatinib + RTB101 DCZVTEJ Dasatinib Malignant melanoma (Cell Line: A375) [3]
Dasatinib + RTB101 DCWNL8S Dasatinib Malignant melanoma (Cell Line: RPMI7951) [3]
Dasatinib + RTB101 DCR87GM Dasatinib Malignant melanoma (Cell Line: UACC62) [3]
Dasatinib + RTB101 DC5I59J Dasatinib Mesothelioma (Cell Line: MSTO) [3]
Dasatinib + RTB101 DC7TF78 Dasatinib Non small cell carcinoma (Cell Line: SKMES1) [3]
Dasatinib + RTB101 DCTKV4P Dasatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Dasatinib + RTB101 DCC7Q3P Dasatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Dasatinib + RTB101 DC1TH0X Dasatinib Prostate carcinoma (Cell Line: LNCAP) [3]
Dasatinib + RTB101 DCA11XE Dasatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Dasatinib + RTB101 DC3DWU3 Dasatinib Breast carcinoma (Cell Line: KPL1) [4]
Dasatinib + RTB101 DCAJCZW Dasatinib Breast carcinoma (Cell Line: OCUBM) [4]
Dasatinib + RTB101 DCG0TK4 Dasatinib Carcinoma (Cell Line: OV90) [4]
Dasatinib + RTB101 DC3XS8V Dasatinib Carcinoma (Cell Line: MDAMB436) [4]
Dasatinib + RTB101 DCZCMLP Dasatinib Colon carcinoma (Cell Line: RKO) [4]
Dasatinib + RTB101 DCT7J7O Dasatinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dasatinib + RTB101 DCCHYFS Dasatinib Rectal adenocarcinoma (Cell Line: SW837) [4]
Dexamethasone + RTB101 DCQR7NG Dexamethasone Breast carcinoma (Cell Line: KPL1) [4]
Dexamethasone + RTB101 DCOCK17 Dexamethasone Adenocarcinoma (Cell Line: CAOV3) [5]
Dexamethasone + RTB101 DCSWWNX Dexamethasone Adenocarcinoma (Cell Line: NCIH2122) [5]
Dexamethasone + RTB101 DCC502R Dexamethasone Mesothelioma (Cell Line: MSTO) [5]
Dexamethasone + RTB101 DCYTC7L Dexamethasone Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Dorsomorphin + RTB101 DCS5M9R Dorsomorphin Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
Dorsomorphin + RTB101 DCPY0K2 Dorsomorphin Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
Doxorubicin + RTB101 DCQI8ID Doxorubicin Adenocarcinoma (Cell Line: OVCAR3) [3]
Doxorubicin + RTB101 DC8262N Doxorubicin Adenocarcinoma (Cell Line: NCIH1650) [3]
Doxorubicin + RTB101 DCVRFRI Doxorubicin Adenocarcinoma (Cell Line: NCIH520) [3]
Doxorubicin + RTB101 DCNCF6R Doxorubicin Adenocarcinoma (Cell Line: COLO320DM) [3]
Doxorubicin + RTB101 DCSDBS9 Doxorubicin Adenocarcinoma (Cell Line: DLD1) [3]
Doxorubicin + RTB101 DCSKA1B Doxorubicin Adenocarcinoma (Cell Line: HCT116) [3]
Doxorubicin + RTB101 DCTJOFS Doxorubicin Adenocarcinoma (Cell Line: HT29) [3]
Doxorubicin + RTB101 DCNFOT4 Doxorubicin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Doxorubicin + RTB101 DCCPH1V Doxorubicin Malignant melanoma (Cell Line: A375) [3]
Doxorubicin + RTB101 DCD1SZV Doxorubicin Malignant melanoma (Cell Line: HT144) [3]
Doxorubicin + RTB101 DCJ0KNW Doxorubicin Malignant melanoma (Cell Line: RPMI7951) [3]
Doxorubicin + RTB101 DC4P4MY Doxorubicin Malignant melanoma (Cell Line: UACC62) [3]
Doxorubicin + RTB101 DCVIXM1 Doxorubicin Non small cell carcinoma (Cell Line: SKMES1) [3]
Doxorubicin + RTB101 DCFFV31 Doxorubicin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Doxorubicin + RTB101 DCLCLIZ Doxorubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Doxorubicin + RTB101 DCFJBQH Doxorubicin Prostate carcinoma (Cell Line: LNCAP) [3]
Doxorubicin + RTB101 DCYP5LL Doxorubicin Prostate carcinoma (Cell Line: VCAP) [3]
Doxorubicin + RTB101 DCGY4D1 Doxorubicin Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Doxorubicin + RTB101 DC3Z1A5 Doxorubicin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Doxorubicin + RTB101 DCX2CZC Doxorubicin Breast carcinoma (Cell Line: ZR751) [4]
Doxorubicin + RTB101 DC54VCW Doxorubicin Breast carcinoma (Cell Line: OCUBM) [4]
Doxorubicin + RTB101 DCHMLTV Doxorubicin Carcinoma (Cell Line: EFM192B) [4]
Doxorubicin + RTB101 DC6EB43 Doxorubicin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Doxorubicin + RTB101 DC5884J Doxorubicin Rectal adenocarcinoma (Cell Line: SW837) [4]
Erlotinib + RTB101 DC2IMRK Erlotinib Adenocarcinoma (Cell Line: CAOV3) [3]
Erlotinib + RTB101 DC6KS73 Erlotinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Erlotinib + RTB101 DCQ0O95 Erlotinib Adenocarcinoma (Cell Line: A427) [3]
Erlotinib + RTB101 DCXHR9O Erlotinib Adenocarcinoma (Cell Line: NCIH2122) [3]
Erlotinib + RTB101 DCHYUVR Erlotinib Adenocarcinoma (Cell Line: NCIH23) [3]
Erlotinib + RTB101 DCCOEML Erlotinib Adenocarcinoma (Cell Line: NCIH520) [3]
Erlotinib + RTB101 DCOGT16 Erlotinib Adenocarcinoma (Cell Line: COLO320DM) [3]
Erlotinib + RTB101 DC2C2Z0 Erlotinib Adenocarcinoma (Cell Line: DLD1) [3]
Erlotinib + RTB101 DCDQFN6 Erlotinib Adenocarcinoma (Cell Line: HT29) [3]
Erlotinib + RTB101 DCLXXKH Erlotinib Amelanotic melanoma (Cell Line: A2058) [3]
Erlotinib + RTB101 DC15FZK Erlotinib Germ cell tumour (Cell Line: PA1) [3]
Erlotinib + RTB101 DC6D0KD Erlotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Erlotinib + RTB101 DC8VFMG Erlotinib Malignant melanoma (Cell Line: A375) [3]
Erlotinib + RTB101 DCQ0Q02 Erlotinib Malignant melanoma (Cell Line: HT144) [3]
Erlotinib + RTB101 DCVYZI7 Erlotinib Malignant melanoma (Cell Line: RPMI7951) [3]
Erlotinib + RTB101 DC95JR4 Erlotinib Malignant melanoma (Cell Line: SKMEL30) [3]
Erlotinib + RTB101 DCAHKIS Erlotinib Malignant melanoma (Cell Line: UACC62) [3]
Erlotinib + RTB101 DCZ4C4N Erlotinib Mesothelioma (Cell Line: MSTO) [3]
Erlotinib + RTB101 DC6DU05 Erlotinib Non small cell carcinoma (Cell Line: SKMES1) [3]
Erlotinib + RTB101 DC7F52W Erlotinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Erlotinib + RTB101 DCRQRZX Erlotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Erlotinib + RTB101 DC70IJ0 Erlotinib Prostate carcinoma (Cell Line: LNCAP) [3]
Erlotinib + RTB101 DC6ED4F Erlotinib Prostate carcinoma (Cell Line: VCAP) [3]
Erlotinib + RTB101 DC769ZM Erlotinib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Erlotinib + RTB101 DC099LD Erlotinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Erlotinib + RTB101 DC4CYPD Erlotinib Breast carcinoma (Cell Line: KPL1) [4]
Erlotinib + RTB101 DCE1L58 Erlotinib Breast carcinoma (Cell Line: OCUBM) [4]
Erlotinib + RTB101 DC5ZZDC Erlotinib Carcinoma (Cell Line: OV90) [4]
Erlotinib + RTB101 DCUKLP1 Erlotinib Carcinoma (Cell Line: EFM192B) [4]
Erlotinib + RTB101 DC6FV1T Erlotinib Carcinoma (Cell Line: MDAMB436) [4]
Erlotinib + RTB101 DCB0DWC Erlotinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Erlotinib + RTB101 DCC6W02 Erlotinib Rectal adenocarcinoma (Cell Line: SW837) [4]
Estramustine + RTB101 DCV8NO5 Estramustine Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Estramustine + RTB101 DC4XUI4 Estramustine Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Estramustine + RTB101 DC3GT33 Estramustine Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Estramustine + RTB101 DCNYEZ5 Estramustine Breast carcinoma (Cell Line: OCUBM) [4]
Estramustine + RTB101 DC29LSD Estramustine Carcinoma (Cell Line: OV90) [4]
Estramustine + RTB101 DCFL1OS Estramustine Carcinoma (Cell Line: EFM192B) [4]
Estramustine + RTB101 DCNC4GN Estramustine Colon adenocarcinoma (Cell Line: LOVO) [4]
Estramustine + RTB101 DC3CRWQ Estramustine Invasive ductal carcinoma (Cell Line: T-47D) [4]
Estramustine + RTB101 DCMD25L Estramustine Adenocarcinoma (Cell Line: CAOV3) [5]
Estramustine + RTB101 DC570BS Estramustine Adenocarcinoma (Cell Line: A427) [5]
Estramustine + RTB101 DCZS4BT Estramustine Adenocarcinoma (Cell Line: NCIH2122) [5]
Estramustine + RTB101 DCBUFC7 Estramustine Adenocarcinoma (Cell Line: NCIH23) [5]
Estramustine + RTB101 DCVWAVK Estramustine Adenocarcinoma (Cell Line: NCIH520) [5]
Estramustine + RTB101 DCVH6SS Estramustine Adenocarcinoma (Cell Line: DLD1) [5]
Estramustine + RTB101 DC0T7S2 Estramustine Adenocarcinoma (Cell Line: HT29) [5]
Estramustine + RTB101 DC9S79Y Estramustine Adenocarcinoma (Cell Line: SW-620) [5]
Estramustine + RTB101 DCQ7QFU Estramustine Amelanotic melanoma (Cell Line: A2058) [5]
Estramustine + RTB101 DCZYUWT Estramustine Germ cell tumour (Cell Line: PA1) [5]
Estramustine + RTB101 DCSWDPY Estramustine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Estramustine + RTB101 DCSDG9F Estramustine Malignant melanoma (Cell Line: A375) [5]
Estramustine + RTB101 DCSC9W4 Estramustine Malignant melanoma (Cell Line: HT144) [5]
Estramustine + RTB101 DCAIK3M Estramustine Malignant melanoma (Cell Line: RPMI7951) [5]
Estramustine + RTB101 DCK7ZE1 Estramustine Malignant melanoma (Cell Line: SKMEL30) [5]
Estramustine + RTB101 DC1SDJJ Estramustine Mesothelioma (Cell Line: MSTO) [5]
Estramustine + RTB101 DC862TP Estramustine Non small cell carcinoma (Cell Line: SKMES1) [5]
Estramustine + RTB101 DC8ZEIC Estramustine Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Estramustine + RTB101 DC8BFJC Estramustine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Etoposide + RTB101 DCLOGBF Etoposide Adenocarcinoma (Cell Line: CAOV3) [3]
Etoposide + RTB101 DC5URWJ Etoposide Adenocarcinoma (Cell Line: A427) [3]
Etoposide + RTB101 DCXJ1DI Etoposide Adenocarcinoma (Cell Line: NCIH2122) [3]
Etoposide + RTB101 DCYJTNR Etoposide Adenocarcinoma (Cell Line: NCIH520) [3]
Etoposide + RTB101 DCRBCPZ Etoposide Adenocarcinoma (Cell Line: COLO320DM) [3]
Etoposide + RTB101 DCRVXQS Etoposide Adenocarcinoma (Cell Line: HCT116) [3]
Etoposide + RTB101 DCM0SFR Etoposide Adenocarcinoma (Cell Line: HT29) [3]
Etoposide + RTB101 DC1WX4U Etoposide Amelanotic melanoma (Cell Line: A2058) [3]
Etoposide + RTB101 DCS84HW Etoposide Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Etoposide + RTB101 DC31F8J Etoposide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Etoposide + RTB101 DCPU5CQ Etoposide Malignant melanoma (Cell Line: A375) [3]
Etoposide + RTB101 DCIPAF8 Etoposide Malignant melanoma (Cell Line: HT144) [3]
Etoposide + RTB101 DCEDP0E Etoposide Malignant melanoma (Cell Line: SKMEL30) [3]
Etoposide + RTB101 DC0OM8K Etoposide Malignant melanoma (Cell Line: UACC62) [3]
Etoposide + RTB101 DCK46GG Etoposide Mesothelioma (Cell Line: MSTO) [3]
Etoposide + RTB101 DCUIA73 Etoposide Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Etoposide + RTB101 DCZ19AK Etoposide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Etoposide + RTB101 DC7LUNV Etoposide Prostate carcinoma (Cell Line: LNCAP) [3]
Etoposide + RTB101 DC904B0 Etoposide Prostate carcinoma (Cell Line: VCAP) [3]
Etoposide + RTB101 DCN1XD8 Etoposide Breast carcinoma (Cell Line: ZR751) [4]
Etoposide + RTB101 DCE2347 Etoposide Breast carcinoma (Cell Line: OCUBM) [4]
Etoposide + RTB101 DC5MYFX Etoposide Carcinoma (Cell Line: OV90) [4]
Etoposide + RTB101 DCXW99M Etoposide Carcinoma (Cell Line: EFM192B) [4]
Etoposide + RTB101 DC9L6XG Etoposide Colon carcinoma (Cell Line: RKO) [4]
Etoposide + RTB101 DC1DBFW Etoposide Invasive ductal carcinoma (Cell Line: T-47D) [4]
Etoposide + RTB101 DCBTNQ3 Etoposide Rectal adenocarcinoma (Cell Line: SW837) [4]
Etoricoxib + RTB101 DCQZLO7 Etoricoxib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Fluorouracil + RTB101 DCOPX9G Fluorouracil Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Fluorouracil + RTB101 DCG6R2J Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Fluorouracil + RTB101 DCZ765I Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Fluorouracil + RTB101 DCLM10J Fluorouracil Breast carcinoma (Cell Line: KPL1) [4]
Fluorouracil + RTB101 DCO29V1 Fluorouracil Breast carcinoma (Cell Line: OCUBM) [4]
Fluorouracil + RTB101 DCU3Q8W Fluorouracil Carcinoma (Cell Line: OV90) [4]
Fluorouracil + RTB101 DCLWLID Fluorouracil Colon adenocarcinoma (Cell Line: LOVO) [4]
Fluorouracil + RTB101 DCQGEN5 Fluorouracil Colon carcinoma (Cell Line: RKO) [4]
Fluorouracil + RTB101 DCEGTQB Fluorouracil Invasive ductal carcinoma (Cell Line: T-47D) [4]
Fluorouracil + RTB101 DC17AQ8 Fluorouracil Adenocarcinoma (Cell Line: CAOV3) [5]
Fluorouracil + RTB101 DC7XW6B Fluorouracil Adenocarcinoma (Cell Line: OVCAR3) [5]
Fluorouracil + RTB101 DC6ACPP Fluorouracil Adenocarcinoma (Cell Line: A427) [5]
Fluorouracil + RTB101 DCM4AKW Fluorouracil Adenocarcinoma (Cell Line: NCIH1650) [5]
Fluorouracil + RTB101 DCCOZY4 Fluorouracil Adenocarcinoma (Cell Line: NCIH2122) [5]
Fluorouracil + RTB101 DCY7J4Q Fluorouracil Adenocarcinoma (Cell Line: NCIH23) [5]
Fluorouracil + RTB101 DCKQ07R Fluorouracil Adenocarcinoma (Cell Line: NCIH520) [5]
Fluorouracil + RTB101 DCKU4TI Fluorouracil Adenocarcinoma (Cell Line: COLO320DM) [5]
Fluorouracil + RTB101 DCS4E7G Fluorouracil Adenocarcinoma (Cell Line: DLD1) [5]
Fluorouracil + RTB101 DCYGLLU Fluorouracil Adenocarcinoma (Cell Line: HCT116) [5]
Fluorouracil + RTB101 DCFE547 Fluorouracil Adenocarcinoma (Cell Line: HT29) [5]
Fluorouracil + RTB101 DCIOLQJ Fluorouracil Germ cell tumour (Cell Line: PA1) [5]
Fluorouracil + RTB101 DCC1IC6 Fluorouracil Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Fluorouracil + RTB101 DCNYI0V Fluorouracil Malignant melanoma (Cell Line: A375) [5]
Fluorouracil + RTB101 DCBPVI0 Fluorouracil Malignant melanoma (Cell Line: RPMI7951) [5]
Fluorouracil + RTB101 DCZ1YYG Fluorouracil Malignant melanoma (Cell Line: SKMEL30) [5]
Fluorouracil + RTB101 DCV659D Fluorouracil Malignant melanoma (Cell Line: UACC62) [5]
Fluorouracil + RTB101 DCWW2DS Fluorouracil Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Fluorouracil + RTB101 DCR1FWK Fluorouracil Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Fluorouracil + RTB101 DCR8D0T Fluorouracil Prostate carcinoma (Cell Line: LNCAP) [5]
Fluorouracil + RTB101 DCPV2CR Fluorouracil Prostate carcinoma (Cell Line: VCAP) [5]
Gemcitabine + RTB101 DCURN6F Gemcitabine Adenocarcinoma (Cell Line: A427) [3]
Gemcitabine + RTB101 DCOUWPX Gemcitabine Adenocarcinoma (Cell Line: NCIH2122) [3]
Gemcitabine + RTB101 DC8C3F2 Gemcitabine Adenocarcinoma (Cell Line: NCIH520) [3]
Gemcitabine + RTB101 DC144E2 Gemcitabine Adenocarcinoma (Cell Line: COLO320DM) [3]
Gemcitabine + RTB101 DCAY25C Gemcitabine Adenocarcinoma (Cell Line: DLD1) [3]
Gemcitabine + RTB101 DC38ZID Gemcitabine Adenocarcinoma (Cell Line: HT29) [3]
Gemcitabine + RTB101 DC9FS1E Gemcitabine Adenocarcinoma (Cell Line: SW-620) [3]
Gemcitabine + RTB101 DCA74AI Gemcitabine Amelanotic melanoma (Cell Line: A2058) [3]
Gemcitabine + RTB101 DC05ROP Gemcitabine Germ cell tumour (Cell Line: PA1) [3]
Gemcitabine + RTB101 DC8VR38 Gemcitabine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Gemcitabine + RTB101 DCIO6IT Gemcitabine Malignant melanoma (Cell Line: HT144) [3]
Gemcitabine + RTB101 DCREE44 Gemcitabine Malignant melanoma (Cell Line: RPMI7951) [3]
Gemcitabine + RTB101 DCXEANM Gemcitabine Malignant melanoma (Cell Line: SKMEL30) [3]
Gemcitabine + RTB101 DC16KGZ Gemcitabine Malignant melanoma (Cell Line: UACC62) [3]
Gemcitabine + RTB101 DC816D2 Gemcitabine Mesothelioma (Cell Line: MSTO) [3]
Gemcitabine + RTB101 DC38TIG Gemcitabine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Gemcitabine + RTB101 DCJDHAH Gemcitabine Prostate carcinoma (Cell Line: LNCAP) [3]
Gemcitabine + RTB101 DCK6IXC Gemcitabine Prostate carcinoma (Cell Line: VCAP) [3]
Gemcitabine + RTB101 DCW1PJB Gemcitabine Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Gemcitabine + RTB101 DCR8JM3 Gemcitabine Breast carcinoma (Cell Line: OCUBM) [4]
Gemcitabine + RTB101 DC4QGMK Gemcitabine Carcinoma (Cell Line: EFM192B) [4]
Gemcitabine + RTB101 DCWSH77 Gemcitabine Carcinoma (Cell Line: MDAMB436) [4]
Gemcitabine + RTB101 DC9SRIU Gemcitabine Colon carcinoma (Cell Line: RKO) [4]
Gemcitabine + RTB101 DCJ475K Gemcitabine Invasive ductal carcinoma (Cell Line: T-47D) [4]
Gemcitabine + RTB101 DCZFPUN Gemcitabine Rectal adenocarcinoma (Cell Line: SW837) [4]
GSK-2256098 + RTB101 DC1WW0D GSK-2256098 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
GSK525762 + RTB101 DCUDUBJ GSK525762 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
GSK525762 + RTB101 DC2MCV8 GSK525762 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
GSK525762 + RTB101 DCALCIV GSK525762 Carcinoma (Cell Line: MDAMB436) [4]
GSK525762 + RTB101 DC73YR0 GSK525762 Adenocarcinoma (Cell Line: A427) [5]
GSK525762 + RTB101 DCEUHW5 GSK525762 Adenocarcinoma (Cell Line: NCIH1650) [5]
GSK525762 + RTB101 DCW0PMM GSK525762 Adenocarcinoma (Cell Line: NCIH2122) [5]
GSK525762 + RTB101 DCNC2IQ GSK525762 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Idarubicin + RTB101 DCDX0LD Idarubicin Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Idarubicin + RTB101 DCFYMW7 Idarubicin Adenocarcinoma (Cell Line: A427) [5]
Idarubicin + RTB101 DCJCJWE Idarubicin Adenocarcinoma (Cell Line: NCIH2122) [5]
Idarubicin + RTB101 DCF1ZZH Idarubicin Adenocarcinoma (Cell Line: NCIH23) [5]
Idarubicin + RTB101 DC206QY Idarubicin Adenocarcinoma (Cell Line: COLO320DM) [5]
Idarubicin + RTB101 DCA3W2Z Idarubicin Amelanotic melanoma (Cell Line: A2058) [5]
Idarubicin + RTB101 DCN1NCB Idarubicin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Idarubicin + RTB101 DCKPVQ7 Idarubicin Malignant melanoma (Cell Line: A375) [5]
Idarubicin + RTB101 DCPUDH1 Idarubicin Malignant melanoma (Cell Line: RPMI7951) [5]
Idarubicin + RTB101 DC6PVEO Idarubicin Malignant melanoma (Cell Line: UACC62) [5]
Idarubicin + RTB101 DCZOMB8 Idarubicin Mesothelioma (Cell Line: MSTO) [5]
Idarubicin + RTB101 DCDHQYZ Idarubicin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Lapatinib + RTB101 DCEO6IL Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Lapatinib + RTB101 DCTPC9J Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Lapatinib + RTB101 DCARH2D Lapatinib Breast carcinoma (Cell Line: ZR751) [4]
Lapatinib + RTB101 DCE9R98 Lapatinib Breast carcinoma (Cell Line: KPL1) [4]
Lapatinib + RTB101 DC8PAWZ Lapatinib Breast carcinoma (Cell Line: OCUBM) [4]
Lapatinib + RTB101 DCUHRPH Lapatinib Carcinoma (Cell Line: OV90) [4]
Lapatinib + RTB101 DCJUEHG Lapatinib Carcinoma (Cell Line: EFM192B) [4]
Lapatinib + RTB101 DCK428S Lapatinib Carcinoma (Cell Line: MDAMB436) [4]
Lapatinib + RTB101 DCXZFWY Lapatinib Colon adenocarcinoma (Cell Line: LOVO) [4]
Lapatinib + RTB101 DC9JWMG Lapatinib Colon carcinoma (Cell Line: RKO) [4]
Lapatinib + RTB101 DCOR7OW Lapatinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Lapatinib + RTB101 DC0A69K Lapatinib Rectal adenocarcinoma (Cell Line: SW837) [4]
Lapatinib + RTB101 DC1QQY0 Lapatinib Adenocarcinoma (Cell Line: CAOV3) [5]
Lapatinib + RTB101 DC8UFPF Lapatinib Adenocarcinoma (Cell Line: A427) [5]
Lapatinib + RTB101 DCPPUAI Lapatinib Adenocarcinoma (Cell Line: NCIH2122) [5]
Lapatinib + RTB101 DCQCC9K Lapatinib Adenocarcinoma (Cell Line: NCIH23) [5]
Lapatinib + RTB101 DCLG5O1 Lapatinib Adenocarcinoma (Cell Line: NCIH520) [5]
Lapatinib + RTB101 DCU28IT Lapatinib Adenocarcinoma (Cell Line: COLO320DM) [5]
Lapatinib + RTB101 DCMAOGS Lapatinib Adenocarcinoma (Cell Line: DLD1) [5]
Lapatinib + RTB101 DCJDKCX Lapatinib Adenocarcinoma (Cell Line: HT29) [5]
Lapatinib + RTB101 DCYDYLZ Lapatinib Amelanotic melanoma (Cell Line: A2058) [5]
Lapatinib + RTB101 DCV9EV8 Lapatinib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [5]
Lapatinib + RTB101 DC7LEZX Lapatinib Malignant melanoma (Cell Line: HT144) [5]
Lapatinib + RTB101 DC53J8N Lapatinib Malignant melanoma (Cell Line: RPMI7951) [5]
Lapatinib + RTB101 DCZUYOE Lapatinib Malignant melanoma (Cell Line: SKMEL30) [5]
Lapatinib + RTB101 DCBRVXC Lapatinib Malignant melanoma (Cell Line: UACC62) [5]
Lapatinib + RTB101 DC5LURT Lapatinib Non small cell carcinoma (Cell Line: SKMES1) [5]
Lapatinib + RTB101 DCV4HEM Lapatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Lapatinib + RTB101 DCEKO7A Lapatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Lapatinib + RTB101 DCVV38E Lapatinib Prostate carcinoma (Cell Line: VCAP) [5]
Larotrectinib + RTB101 DCSL9Q4 Larotrectinib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Metformin + RTB101 DC4RKRJ Metformin Adenocarcinoma (Cell Line: NCIH2122) [3]
Metformin + RTB101 DCU8GWO Metformin Adenocarcinoma (Cell Line: NCIH520) [3]
Metformin + RTB101 DCB3ONA Metformin Adenocarcinoma (Cell Line: HT29) [3]
Metformin + RTB101 DCTXG0P Metformin Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Metformin + RTB101 DCKNIBB Metformin Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Metformin + RTB101 DCEU735 Metformin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Metformin + RTB101 DCNDSDS Metformin Breast carcinoma (Cell Line: OCUBM) [4]
Metformin + RTB101 DCOJWZS Metformin Carcinoma (Cell Line: OV90) [4]
Metformin + RTB101 DCE25JH Metformin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Methotrexate + RTB101 DCM1FC4 Methotrexate Adenocarcinoma (Cell Line: NCIH520) [3]
Methotrexate + RTB101 DCU92EV Methotrexate Malignant melanoma (Cell Line: HT144) [3]
Methotrexate + RTB101 DCPF8VI Methotrexate Malignant melanoma (Cell Line: SKMEL30) [3]
Methotrexate + RTB101 DC1IHTV Methotrexate Mesothelioma (Cell Line: MSTO) [3]
Methotrexate + RTB101 DCLJKGK Methotrexate Carcinoma (Cell Line: OV90) [4]
Methotrexate + RTB101 DCNKCUV Methotrexate Carcinoma (Cell Line: EFM192B) [4]
Methotrexate + RTB101 DCEQQJY Methotrexate Rectal adenocarcinoma (Cell Line: SW837) [4]
Mitomycin + RTB101 DCIKPT5 Mitomycin Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Mitomycin + RTB101 DCK8MUW Mitomycin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Mitomycin + RTB101 DCOHUWC Mitomycin Breast carcinoma (Cell Line: KPL1) [4]
Mitomycin + RTB101 DCVYJ9L Mitomycin Breast carcinoma (Cell Line: OCUBM) [4]
Mitomycin + RTB101 DCL4HCM Mitomycin Carcinoma (Cell Line: EFM192B) [4]
Mitomycin + RTB101 DCI16HP Mitomycin Colon adenocarcinoma (Cell Line: LOVO) [4]
Mitomycin + RTB101 DCSVLFS Mitomycin Colon carcinoma (Cell Line: RKO) [4]
Mitomycin + RTB101 DC55PDF Mitomycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Mitomycin + RTB101 DCLAQNO Mitomycin Rectal adenocarcinoma (Cell Line: SW837) [4]
Mitomycin + RTB101 DC9M8WR Mitomycin Adenocarcinoma (Cell Line: CAOV3) [5]
Mitomycin + RTB101 DC3MM4R Mitomycin Adenocarcinoma (Cell Line: A427) [5]
Mitomycin + RTB101 DCC5KW4 Mitomycin Adenocarcinoma (Cell Line: NCIH1650) [5]
Mitomycin + RTB101 DC2PEHD Mitomycin Adenocarcinoma (Cell Line: NCIH2122) [5]
Mitomycin + RTB101 DC8DCA7 Mitomycin Adenocarcinoma (Cell Line: NCIH23) [5]
Mitomycin + RTB101 DCB5VFW Mitomycin Adenocarcinoma (Cell Line: NCIH520) [5]
Mitomycin + RTB101 DC3XOTO Mitomycin Adenocarcinoma (Cell Line: COLO320DM) [5]
Mitomycin + RTB101 DCXS277 Mitomycin Adenocarcinoma (Cell Line: HCT116) [5]
Mitomycin + RTB101 DCS9G7D Mitomycin Adenocarcinoma (Cell Line: HT29) [5]
Mitomycin + RTB101 DCVS08X Mitomycin Adenocarcinoma (Cell Line: SW-620) [5]
Mitomycin + RTB101 DCABD2S Mitomycin Amelanotic melanoma (Cell Line: A2058) [5]
Mitomycin + RTB101 DCI0GIS Mitomycin Germ cell tumour (Cell Line: PA1) [5]
Mitomycin + RTB101 DCU7X6B Mitomycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Mitomycin + RTB101 DCKJPKL Mitomycin Malignant melanoma (Cell Line: A375) [5]
Mitomycin + RTB101 DCIU09T Mitomycin Malignant melanoma (Cell Line: HT144) [5]
Mitomycin + RTB101 DCFL4Z3 Mitomycin Malignant melanoma (Cell Line: SKMEL30) [5]
Mitomycin + RTB101 DCBZ04G Mitomycin Malignant melanoma (Cell Line: UACC62) [5]
Mitomycin + RTB101 DCI58FG Mitomycin Mesothelioma (Cell Line: MSTO) [5]
Mitomycin + RTB101 DC2TQ2W Mitomycin Non small cell carcinoma (Cell Line: SKMES1) [5]
Mitomycin + RTB101 DCICKB5 Mitomycin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Mitomycin + RTB101 DCFB33K Mitomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Mitomycin + RTB101 DC358J9 Mitomycin Prostate carcinoma (Cell Line: VCAP) [5]
Mitomycin + RTB101 DCX5RWL Mitomycin Prostate carcinoma (Cell Line: LNCAP) [5]
MK-1775 + RTB101 DCYFEOJ MK-1775 Adenocarcinoma (Cell Line: NCIH2122) [3]
MK-1775 + RTB101 DCYBXH5 MK-1775 Adenocarcinoma (Cell Line: NCIH520) [3]
MK-1775 + RTB101 DCXSHM2 MK-1775 Adenocarcinoma (Cell Line: COLO320DM) [3]
MK-1775 + RTB101 DCU4EYH MK-1775 Adenocarcinoma (Cell Line: DLD1) [3]
MK-1775 + RTB101 DCWZQV8 MK-1775 Adenocarcinoma (Cell Line: HCT116) [3]
MK-1775 + RTB101 DCZXAT9 MK-1775 Adenocarcinoma (Cell Line: HT29) [3]
MK-1775 + RTB101 DC8VZYT MK-1775 Adenocarcinoma (Cell Line: SW-620) [3]
MK-1775 + RTB101 DCR0DKK MK-1775 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
MK-1775 + RTB101 DCG0FU7 MK-1775 Germ cell tumour (Cell Line: PA1) [3]
MK-1775 + RTB101 DCMRDUC MK-1775 Malignant melanoma (Cell Line: A375) [3]
MK-1775 + RTB101 DCFOKO1 MK-1775 Malignant melanoma (Cell Line: HT144) [3]
MK-1775 + RTB101 DCB5IYJ MK-1775 Malignant melanoma (Cell Line: RPMI7951) [3]
MK-1775 + RTB101 DC2TQK3 MK-1775 Malignant melanoma (Cell Line: SKMEL30) [3]
MK-1775 + RTB101 DCN9LZK MK-1775 Mesothelioma (Cell Line: MSTO) [3]
MK-1775 + RTB101 DCVY5FW MK-1775 Non small cell carcinoma (Cell Line: SKMES1) [3]
MK-1775 + RTB101 DC8BRH3 MK-1775 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
MK-1775 + RTB101 DCK432M MK-1775 Prostate carcinoma (Cell Line: LNCAP) [3]
MK-1775 + RTB101 DCFXWB4 MK-1775 Prostate carcinoma (Cell Line: VCAP) [3]
MK-1775 + RTB101 DCXGPKA MK-1775 Breast carcinoma (Cell Line: ZR751) [4]
MK-1775 + RTB101 DC0HHQV MK-1775 Breast carcinoma (Cell Line: OCUBM) [4]
MK-1775 + RTB101 DCPXFEZ MK-1775 Carcinoma (Cell Line: EFM192B) [4]
MK-1775 + RTB101 DCLY0HZ MK-1775 Carcinoma (Cell Line: MDAMB436) [4]
MK-1775 + RTB101 DC1BAGP MK-1775 Colon adenocarcinoma (Cell Line: LOVO) [4]
MK-1775 + RTB101 DCYH32Q MK-1775 Colon carcinoma (Cell Line: RKO) [4]
MK-1775 + RTB101 DCDU3HX MK-1775 Invasive ductal carcinoma (Cell Line: T-47D) [4]
MK-2206 + RTB101 DCFETFN MK-2206 Adenocarcinoma (Cell Line: OVCAR3) [3]
MK-2206 + RTB101 DC4KVDN MK-2206 Adenocarcinoma (Cell Line: A427) [3]
MK-2206 + RTB101 DCAB40L MK-2206 Adenocarcinoma (Cell Line: NCIH1650) [3]
MK-2206 + RTB101 DC4NSRE MK-2206 Adenocarcinoma (Cell Line: NCIH2122) [3]
MK-2206 + RTB101 DCD6SBT MK-2206 Adenocarcinoma (Cell Line: NCIH23) [3]
MK-2206 + RTB101 DCE19QT MK-2206 Adenocarcinoma (Cell Line: COLO320DM) [3]
MK-2206 + RTB101 DC7T7DN MK-2206 Adenocarcinoma (Cell Line: HCT116) [3]
MK-2206 + RTB101 DCDSGVS MK-2206 Adenocarcinoma (Cell Line: HT29) [3]
MK-2206 + RTB101 DCSANPA MK-2206 Amelanotic melanoma (Cell Line: A2058) [3]
MK-2206 + RTB101 DCNMWRF MK-2206 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
MK-2206 + RTB101 DCNH6J2 MK-2206 Germ cell tumour (Cell Line: PA1) [3]
MK-2206 + RTB101 DC5JP4V MK-2206 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
MK-2206 + RTB101 DCRGVC8 MK-2206 Malignant melanoma (Cell Line: HT144) [3]
MK-2206 + RTB101 DCYAJ4Q MK-2206 Malignant melanoma (Cell Line: RPMI7951) [3]
MK-2206 + RTB101 DCXF5Q2 MK-2206 Malignant melanoma (Cell Line: SKMEL30) [3]
MK-2206 + RTB101 DCIHS7F MK-2206 Malignant melanoma (Cell Line: UACC62) [3]
MK-2206 + RTB101 DCNO56T MK-2206 Mesothelioma (Cell Line: MSTO) [3]
MK-2206 + RTB101 DC2TW5C MK-2206 Non small cell carcinoma (Cell Line: SKMES1) [3]
MK-2206 + RTB101 DCD99YX MK-2206 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
MK-2206 + RTB101 DCGCIY5 MK-2206 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
MK-2206 + RTB101 DC32UPR MK-2206 Prostate carcinoma (Cell Line: LNCAP) [3]
MK-2206 + RTB101 DC81SV1 MK-2206 Prostate carcinoma (Cell Line: VCAP) [3]
MK-2206 + RTB101 DC6F3XI MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
MK-2206 + RTB101 DCSZ10L MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
MK-2206 + RTB101 DCLS9YB MK-2206 Breast carcinoma (Cell Line: KPL1) [4]
MK-2206 + RTB101 DCC9UXA MK-2206 Breast carcinoma (Cell Line: OCUBM) [4]
MK-2206 + RTB101 DCK8R0A MK-2206 Carcinoma (Cell Line: OV90) [4]
MK-2206 + RTB101 DC362AB MK-2206 Carcinoma (Cell Line: EFM192B) [4]
MK-2206 + RTB101 DC3126A MK-2206 Carcinoma (Cell Line: MDAMB436) [4]
MK-2206 + RTB101 DC8SB7C MK-2206 Colon carcinoma (Cell Line: RKO) [4]
MK-2206 + RTB101 DC20UVO MK-2206 Invasive ductal carcinoma (Cell Line: T-47D) [4]
MK-2206 + RTB101 DCNVYMR MK-2206 Rectal adenocarcinoma (Cell Line: SW837) [4]
MK-4827 + RTB101 DCD723T MK-4827 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
MK-4827 + RTB101 DCU6HS1 MK-4827 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
MK-4827 + RTB101 DC84CA9 MK-4827 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
MK-4827 + RTB101 DCN7SGM MK-4827 Breast carcinoma (Cell Line: ZR751) [4]
MK-4827 + RTB101 DC87O78 MK-4827 Breast carcinoma (Cell Line: KPL1) [4]
MK-4827 + RTB101 DCKIE1M MK-4827 Breast carcinoma (Cell Line: OCUBM) [4]
MK-4827 + RTB101 DCEELWL MK-4827 Carcinoma (Cell Line: OV90) [4]
MK-4827 + RTB101 DCZIJID MK-4827 Carcinoma (Cell Line: EFM192B) [4]
MK-4827 + RTB101 DC2MZW9 MK-4827 Carcinoma (Cell Line: MDAMB436) [4]
MK-4827 + RTB101 DCK01CR MK-4827 Colon adenocarcinoma (Cell Line: LOVO) [4]
MK-4827 + RTB101 DCP62QP MK-4827 Colon carcinoma (Cell Line: RKO) [4]
MK-4827 + RTB101 DCM5A9G MK-4827 Invasive ductal carcinoma (Cell Line: T-47D) [4]
MK-4827 + RTB101 DC0MC7G MK-4827 Rectal adenocarcinoma (Cell Line: SW837) [4]
MK-4827 + RTB101 DC73NTU MK-4827 Adenocarcinoma (Cell Line: CAOV3) [5]
MK-4827 + RTB101 DCRA69Y MK-4827 Adenocarcinoma (Cell Line: OVCAR3) [5]
MK-4827 + RTB101 DC41PDY MK-4827 Adenocarcinoma (Cell Line: A427) [5]
MK-4827 + RTB101 DCDD7TA MK-4827 Adenocarcinoma (Cell Line: NCIH1650) [5]
MK-4827 + RTB101 DCXJT2O MK-4827 Adenocarcinoma (Cell Line: NCIH2122) [5]
MK-4827 + RTB101 DCVSPSC MK-4827 Adenocarcinoma (Cell Line: NCIH23) [5]
MK-4827 + RTB101 DCFMSGR MK-4827 Adenocarcinoma (Cell Line: NCIH520) [5]
MK-4827 + RTB101 DCLO61D MK-4827 Adenocarcinoma (Cell Line: COLO320DM) [5]
MK-4827 + RTB101 DCP3DTI MK-4827 Adenocarcinoma (Cell Line: DLD1) [5]
MK-4827 + RTB101 DCGIHIB MK-4827 Adenocarcinoma (Cell Line: HCT116) [5]
MK-4827 + RTB101 DC2I1PQ MK-4827 Adenocarcinoma (Cell Line: HT29) [5]
MK-4827 + RTB101 DC0SQ46 MK-4827 Adenocarcinoma (Cell Line: SW-620) [5]
MK-4827 + RTB101 DCMIY7Q MK-4827 Amelanotic melanoma (Cell Line: A2058) [5]
MK-4827 + RTB101 DCE28IL MK-4827 Germ cell tumour (Cell Line: PA1) [5]
MK-4827 + RTB101 DCC4HKB MK-4827 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
MK-4827 + RTB101 DC1SLZC MK-4827 Malignant melanoma (Cell Line: HT144) [5]
MK-4827 + RTB101 DC5ENSD MK-4827 Malignant melanoma (Cell Line: RPMI7951) [5]
MK-4827 + RTB101 DCVFPMO MK-4827 Malignant melanoma (Cell Line: SKMEL30) [5]
MK-4827 + RTB101 DCBT7KV MK-4827 Malignant melanoma (Cell Line: UACC62) [5]
MK-4827 + RTB101 DCDIM50 MK-4827 Malignant melanoma (Cell Line: A375) [5]
MK-4827 + RTB101 DCGNDWF MK-4827 Mesothelioma (Cell Line: MSTO) [5]
MK-4827 + RTB101 DCTEKI5 MK-4827 Non small cell carcinoma (Cell Line: SKMES1) [5]
MK-4827 + RTB101 DCICY6D MK-4827 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
MK-4827 + RTB101 DCBA8UJ MK-4827 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
MK-4827 + RTB101 DCMZVH6 MK-4827 Prostate carcinoma (Cell Line: LNCAP) [5]
MK-4827 + RTB101 DCCKFAM MK-4827 Prostate carcinoma (Cell Line: VCAP) [5]
MK-5108 + RTB101 DCTOAFZ MK-5108 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
MK-5108 + RTB101 DCPWM10 MK-5108 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
MK-5108 + RTB101 DCI8VGW MK-5108 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
MK-5108 + RTB101 DCJ0R7O MK-5108 Breast carcinoma (Cell Line: OCUBM) [4]
MK-5108 + RTB101 DC0MBUE MK-5108 Carcinoma (Cell Line: EFM192B) [4]
MK-5108 + RTB101 DCJSAE3 MK-5108 Carcinoma (Cell Line: MDAMB436) [4]
MK-5108 + RTB101 DCG5Z5Q MK-5108 Colon adenocarcinoma (Cell Line: LOVO) [4]
MK-5108 + RTB101 DCPB7L4 MK-5108 Invasive ductal carcinoma (Cell Line: T-47D) [4]
MK-5108 + RTB101 DCGX3N2 MK-5108 Adenocarcinoma (Cell Line: CAOV3) [5]
MK-5108 + RTB101 DC38E6Y MK-5108 Adenocarcinoma (Cell Line: A427) [5]
MK-5108 + RTB101 DC3ZAIZ MK-5108 Adenocarcinoma (Cell Line: NCIH2122) [5]
MK-5108 + RTB101 DCWSQJO MK-5108 Adenocarcinoma (Cell Line: NCIH520) [5]
MK-5108 + RTB101 DCFXDSX MK-5108 Adenocarcinoma (Cell Line: HT29) [5]
MK-5108 + RTB101 DC2YLWS MK-5108 Amelanotic melanoma (Cell Line: A2058) [5]
MK-5108 + RTB101 DC6RGCD MK-5108 Germ cell tumour (Cell Line: PA1) [5]
MK-5108 + RTB101 DCNKF7S MK-5108 Malignant melanoma (Cell Line: HT144) [5]
MK-5108 + RTB101 DCJT0W2 MK-5108 Malignant melanoma (Cell Line: RPMI7951) [5]
MK-5108 + RTB101 DCHAO2N MK-5108 Malignant melanoma (Cell Line: SKMEL30) [5]
MK-5108 + RTB101 DCD44TR MK-5108 Malignant melanoma (Cell Line: UACC62) [5]
MK-5108 + RTB101 DCSM853 MK-5108 Mesothelioma (Cell Line: MSTO) [5]
MK-5108 + RTB101 DCZEFPF MK-5108 Non small cell carcinoma (Cell Line: SKMES1) [5]
MK-5108 + RTB101 DCHAJJC MK-5108 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
MK-5108 + RTB101 DC9I9LM MK-5108 Prostate carcinoma (Cell Line: VCAP) [5]
PAC1 + RTB101 DCTJGSM PAC1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
PD-0325901 + RTB101 DCHG6IW PD-0325901 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
PD-0325901 + RTB101 DCTM3VE PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
PD-0325901 + RTB101 DCKZH62 PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
PD-0325901 + RTB101 DCEDYFA PD-0325901 Breast carcinoma (Cell Line: ZR751) [4]
PD-0325901 + RTB101 DC2ILKL PD-0325901 Breast carcinoma (Cell Line: KPL1) [4]
PD-0325901 + RTB101 DCPM3II PD-0325901 Breast carcinoma (Cell Line: OCUBM) [4]
PD-0325901 + RTB101 DCN3XQN PD-0325901 Carcinoma (Cell Line: OV90) [4]
PD-0325901 + RTB101 DC6WT64 PD-0325901 Carcinoma (Cell Line: EFM192B) [4]
PD-0325901 + RTB101 DCPUY32 PD-0325901 Carcinoma (Cell Line: MDAMB436) [4]
PD-0325901 + RTB101 DCN0JL8 PD-0325901 Colon adenocarcinoma (Cell Line: LOVO) [4]
PD-0325901 + RTB101 DCH9U1A PD-0325901 Colon carcinoma (Cell Line: RKO) [4]
PD-0325901 + RTB101 DCRND9F PD-0325901 Invasive ductal carcinoma (Cell Line: T-47D) [4]
PD-0325901 + RTB101 DC86USJ PD-0325901 Rectal adenocarcinoma (Cell Line: SW837) [4]
PD-0325901 + RTB101 DCFB7O3 PD-0325901 Adenocarcinoma (Cell Line: CAOV3) [5]
PD-0325901 + RTB101 DC5NU0B PD-0325901 Adenocarcinoma (Cell Line: OVCAR3) [5]
PD-0325901 + RTB101 DCHYLB2 PD-0325901 Adenocarcinoma (Cell Line: A427) [5]
PD-0325901 + RTB101 DCY3E9X PD-0325901 Adenocarcinoma (Cell Line: NCIH1650) [5]
PD-0325901 + RTB101 DCHX48N PD-0325901 Adenocarcinoma (Cell Line: NCIH2122) [5]
PD-0325901 + RTB101 DCZSQAH PD-0325901 Adenocarcinoma (Cell Line: NCIH23) [5]
PD-0325901 + RTB101 DC7NVA4 PD-0325901 Adenocarcinoma (Cell Line: NCIH520) [5]
PD-0325901 + RTB101 DCLN7SX PD-0325901 Adenocarcinoma (Cell Line: COLO320DM) [5]
PD-0325901 + RTB101 DCN3FID PD-0325901 Adenocarcinoma (Cell Line: DLD1) [5]
PD-0325901 + RTB101 DCW0LPT PD-0325901 Adenocarcinoma (Cell Line: HCT116) [5]
PD-0325901 + RTB101 DCIUYQX PD-0325901 Adenocarcinoma (Cell Line: HT29) [5]
PD-0325901 + RTB101 DCFV71Z PD-0325901 Adenocarcinoma (Cell Line: SW-620) [5]
PD-0325901 + RTB101 DCBI61E PD-0325901 Amelanotic melanoma (Cell Line: A2058) [5]
PD-0325901 + RTB101 DCZZBRM PD-0325901 Germ cell tumour (Cell Line: PA1) [5]
PD-0325901 + RTB101 DCEPD3N PD-0325901 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
PD-0325901 + RTB101 DC7FWAR PD-0325901 Malignant melanoma (Cell Line: A375) [5]
PD-0325901 + RTB101 DC9WGZO PD-0325901 Malignant melanoma (Cell Line: HT144) [5]
PD-0325901 + RTB101 DC3VYTE PD-0325901 Malignant melanoma (Cell Line: RPMI7951) [5]
PD-0325901 + RTB101 DCUX0F4 PD-0325901 Malignant melanoma (Cell Line: SKMEL30) [5]
PD-0325901 + RTB101 DCGAX8R PD-0325901 Malignant melanoma (Cell Line: UACC62) [5]
PD-0325901 + RTB101 DC6R2WZ PD-0325901 Mesothelioma (Cell Line: MSTO) [5]
PD-0325901 + RTB101 DC9WT2Z PD-0325901 Non small cell carcinoma (Cell Line: SKMES1) [5]
PD-0325901 + RTB101 DCE7LLI PD-0325901 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
PD-0325901 + RTB101 DCPRLUJ PD-0325901 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
PD-0325901 + RTB101 DCD8UNT PD-0325901 Prostate carcinoma (Cell Line: LNCAP) [5]
PD-0325901 + RTB101 DC4ZVBR PD-0325901 Prostate carcinoma (Cell Line: VCAP) [5]
PHA848125 + RTB101 DC3DZNI PHA848125 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
PMID28460551-Compound-2 + RTB101 DC8KPP0 PMID28460551-Compound-2 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
PMID28460551-Compound-2 + RTB101 DC9NBS4 PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
PMID28460551-Compound-2 + RTB101 DCGBRNJ PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
PMID28460551-Compound-2 + RTB101 DCF4WBW PMID28460551-Compound-2 Breast carcinoma (Cell Line: ZR751) [4]
PMID28460551-Compound-2 + RTB101 DCO1LZ2 PMID28460551-Compound-2 Breast carcinoma (Cell Line: KPL1) [4]
PMID28460551-Compound-2 + RTB101 DC27CDY PMID28460551-Compound-2 Breast carcinoma (Cell Line: OCUBM) [4]
PMID28460551-Compound-2 + RTB101 DCXSJP1 PMID28460551-Compound-2 Carcinoma (Cell Line: OV90) [4]
PMID28460551-Compound-2 + RTB101 DCHPJ5X PMID28460551-Compound-2 Carcinoma (Cell Line: EFM192B) [4]
PMID28460551-Compound-2 + RTB101 DCET4HM PMID28460551-Compound-2 Carcinoma (Cell Line: MDAMB436) [4]
PMID28460551-Compound-2 + RTB101 DC83G70 PMID28460551-Compound-2 Colon adenocarcinoma (Cell Line: LOVO) [4]
PMID28460551-Compound-2 + RTB101 DC87P6H PMID28460551-Compound-2 Colon carcinoma (Cell Line: RKO) [4]
PMID28460551-Compound-2 + RTB101 DCRE0CW PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: T-47D) [4]
PMID28460551-Compound-2 + RTB101 DCT0WDH PMID28460551-Compound-2 Rectal adenocarcinoma (Cell Line: SW837) [4]
PMID28460551-Compound-2 + RTB101 DC7H8ZE PMID28460551-Compound-2 Adenocarcinoma (Cell Line: CAOV3) [5]
PMID28460551-Compound-2 + RTB101 DCY62RB PMID28460551-Compound-2 Adenocarcinoma (Cell Line: OVCAR3) [5]
PMID28460551-Compound-2 + RTB101 DCA0S7H PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH2122) [5]
PMID28460551-Compound-2 + RTB101 DCMNFOH PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH23) [5]
PMID28460551-Compound-2 + RTB101 DCUNGWO PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH520) [5]
PMID28460551-Compound-2 + RTB101 DCFO3O6 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: COLO320DM) [5]
PMID28460551-Compound-2 + RTB101 DCTNFXU PMID28460551-Compound-2 Adenocarcinoma (Cell Line: DLD1) [5]
PMID28460551-Compound-2 + RTB101 DC1BYEF PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HCT116) [5]
PMID28460551-Compound-2 + RTB101 DCODHD0 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HT29) [5]
PMID28460551-Compound-2 + RTB101 DCHKVPS PMID28460551-Compound-2 Adenocarcinoma (Cell Line: SW-620) [5]
PMID28460551-Compound-2 + RTB101 DCIF6M4 PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: A2058) [5]
PMID28460551-Compound-2 + RTB101 DCKNLGD PMID28460551-Compound-2 Germ cell tumour (Cell Line: PA1) [5]
PMID28460551-Compound-2 + RTB101 DCWBW8S PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
PMID28460551-Compound-2 + RTB101 DCWHOCA PMID28460551-Compound-2 Malignant melanoma (Cell Line: A375) [5]
PMID28460551-Compound-2 + RTB101 DCP0YTE PMID28460551-Compound-2 Malignant melanoma (Cell Line: HT144) [5]
PMID28460551-Compound-2 + RTB101 DC7LMRI PMID28460551-Compound-2 Malignant melanoma (Cell Line: RPMI7951) [5]
PMID28460551-Compound-2 + RTB101 DCPN52Y PMID28460551-Compound-2 Malignant melanoma (Cell Line: SKMEL30) [5]
PMID28460551-Compound-2 + RTB101 DC7DLXM PMID28460551-Compound-2 Malignant melanoma (Cell Line: UACC62) [5]
PMID28460551-Compound-2 + RTB101 DCNDF03 PMID28460551-Compound-2 Mesothelioma (Cell Line: MSTO) [5]
PMID28460551-Compound-2 + RTB101 DCR7062 PMID28460551-Compound-2 Non small cell carcinoma (Cell Line: SKMES1) [5]
PMID28460551-Compound-2 + RTB101 DCGOPGW PMID28460551-Compound-2 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
PMID28460551-Compound-2 + RTB101 DCS724X PMID28460551-Compound-2 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
PMID28460551-Compound-2 + RTB101 DCYZ3TK PMID28460551-Compound-2 Prostate carcinoma (Cell Line: LNCAP) [5]
PMID28460551-Compound-2 + RTB101 DCVXLTP PMID28460551-Compound-2 Prostate carcinoma (Cell Line: VCAP) [5]
Prochlorperazine + RTB101 DCSCEL7 Prochlorperazine Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + Gefitinib DCZ9GJK Gefitinib Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + Gefitinib DC6UWIV Gefitinib Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + Ruxolitinib DC265RO Ruxolitinib T-cell leukemia/lymphoma (Cell Line: ED-40515) [3]
RTB101 + PD-0325901 DCFKO78 PD-0325901 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + PD-0325901 DCK7WYH PD-0325901 Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + Trametinib DCI41AE Trametinib Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + JQ1 DC46MY2 JQ1 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + JQ1 DCG35RB JQ1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + Carfilzomib DCN9DEL Carfilzomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + Panobinostat DCOL24G Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + Panobinostat DCX0FAM Panobinostat Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + Panobinostat DCLJAZU Panobinostat Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + SCH-900776 DCLNLE2 SCH-900776 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
RTB101 + Acalabrutinib DC3LEMX Acalabrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [3]
RTB101 + Abexinostat DCF3SL2 Abexinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + 10-hydroxycamptothecin DCEI2EO 10-hydroxycamptothecin Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
RTB101 + CUDC-101 DCP87VX CUDC-101 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + CUDC-101 DC1DRHZ CUDC-101 Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + RAF265 DC6C18S RAF265 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + Parthenolide DCN7VTJ Parthenolide Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + THAPSIGARGIN DCY7G9P THAPSIGARGIN Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + THAPSIGARGIN DC5OWWA THAPSIGARGIN Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + GDC-0980/RG7422 DC7CCIO GDC-0980/RG7422 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + SNDX-275 DCSNU5R SNDX-275 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + SNDX-275 DCDBQM3 SNDX-275 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + Tamoxifen DCSUK3R Tamoxifen Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + Tamoxifen DCB91XB Tamoxifen Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + Ridaforolimus DCG1N85 Ridaforolimus Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
RTB101 + Idarubicin DCV9N5G Idarubicin Glioblastoma? (Cell Line: T98G) [3]
RTB101 + Ciclopirox DC5B5FF Ciclopirox Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + Resminostat DCJOA8Z Resminostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + ABT-263 DCPY2E2 ABT-263 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + MLN8237 DCWYMQG MLN8237 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + CF102 DC9WTC5 CF102 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + BIIB-021 DCXD9FC BIIB-021 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + BMS-754807 DCCU8JN BMS-754807 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + BMS-754807 DC4NMG7 BMS-754807 Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + Citarinostat DCTB8RL Citarinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + Sorafenib DCWSFWI Sorafenib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
RTB101 + Prazosin DCCTQBV Prazosin Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + Chloroquine DCLC3IB Chloroquine Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + PF-562271 DC5X7EN PF-562271 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + PF-562271 DCZ6RQ7 PF-562271 Diffuse large B cell lymphoma (Cell Line: TMD8) [3]
RTB101 + PF-562271 DCJ4NFR PF-562271 Primitive neuroectodermal tumor (Cell Line: TC-32) [3]
RTB101 + NVP-AUY922 DCT9EFX NVP-AUY922 Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + THZ1 DCHFGO8 THZ1 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + Vinpocetine DC6U2VI Vinpocetine Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII) [3]
RTB101 + Sodium valproate DCXUXOD Sodium valproate Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + CB3304 DCZ9Z4K CB3304 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
RTB101 + Ibrutinib DCBDYYO Ibrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [3]
RTB101 + SCH-900776 DCJTRP0 SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
RTB101 + SCH-900776 DCMMMHJ SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
RTB101 + SCH-900776 DCXS7DH SCH-900776 Carcinoma (Cell Line: OV90) [4]
RTB101 + SCH-900776 DCWJIQJ SCH-900776 Carcinoma (Cell Line: MDAMB436) [4]
RTB101 + SCH-900776 DC0AU7S SCH-900776 Colon carcinoma (Cell Line: RKO) [4]
RTB101 + 10-hydroxycamptothecin DC70T79 10-hydroxycamptothecin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
RTB101 + 10-hydroxycamptothecin DCO7IGG 10-hydroxycamptothecin Breast carcinoma (Cell Line: KPL1) [4]
RTB101 + 10-hydroxycamptothecin DCAQ2G2 10-hydroxycamptothecin Breast carcinoma (Cell Line: OCUBM) [4]
RTB101 + 10-hydroxycamptothecin DCANIEV 10-hydroxycamptothecin Carcinoma (Cell Line: OV90) [4]
RTB101 + 10-hydroxycamptothecin DCLV1F4 10-hydroxycamptothecin Carcinoma (Cell Line: EFM192B) [4]
RTB101 + 10-hydroxycamptothecin DC1OJR8 10-hydroxycamptothecin Carcinoma (Cell Line: MDAMB436) [4]
RTB101 + 10-hydroxycamptothecin DCQF1SQ 10-hydroxycamptothecin Colon adenocarcinoma (Cell Line: LOVO) [4]
RTB101 + 10-hydroxycamptothecin DCIUOPX 10-hydroxycamptothecin Colon carcinoma (Cell Line: RKO) [4]
RTB101 + 10-hydroxycamptothecin DCVV2VP 10-hydroxycamptothecin Invasive ductal carcinoma (Cell Line: T-47D) [4]
RTB101 + Ridaforolimus DCDS03D Ridaforolimus Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
RTB101 + Ridaforolimus DCXFJ3A Ridaforolimus Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
RTB101 + Ridaforolimus DCLQE0M Ridaforolimus Breast carcinoma (Cell Line: KPL1) [4]
RTB101 + Ridaforolimus DCL12U8 Ridaforolimus Breast carcinoma (Cell Line: OCUBM) [4]
RTB101 + Ridaforolimus DCVCHPB Ridaforolimus Carcinoma (Cell Line: OV90) [4]
RTB101 + Ridaforolimus DC42M44 Ridaforolimus Carcinoma (Cell Line: EFM192B) [4]
RTB101 + Ridaforolimus DCSMB49 Ridaforolimus Carcinoma (Cell Line: MDAMB436) [4]
RTB101 + Ridaforolimus DC32D75 Ridaforolimus Colon adenocarcinoma (Cell Line: LOVO) [4]
RTB101 + Ridaforolimus DCON33B Ridaforolimus Colon carcinoma (Cell Line: RKO) [4]
RTB101 + Ridaforolimus DCQBGAY Ridaforolimus Invasive ductal carcinoma (Cell Line: T-47D) [4]
RTB101 + Ridaforolimus DCB3AZD Ridaforolimus Rectal adenocarcinoma (Cell Line: SW837) [4]
RTB101 + Lomustine DCJ9XJF Lomustine Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
RTB101 + Lomustine DCGNUZG Lomustine Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
RTB101 + Lomustine DCGS356 Lomustine Breast carcinoma (Cell Line: KPL1) [4]
RTB101 + Lomustine DCO1OM9 Lomustine Breast carcinoma (Cell Line: OCUBM) [4]
RTB101 + Lomustine DCY6OHD Lomustine Carcinoma (Cell Line: EFM192B) [4]
RTB101 + Lomustine DC2NKIV Lomustine Invasive ductal carcinoma (Cell Line: T-47D) [4]
RTB101 + Sorafenib DC5M4WP Sorafenib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
RTB101 + Sorafenib DCVZWY1 Sorafenib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
RTB101 + Sorafenib DCF2M9K Sorafenib Breast carcinoma (Cell Line: OCUBM) [4]
RTB101 + Sorafenib DCOPYPO Sorafenib Carcinoma (Cell Line: OV90) [4]
RTB101 + Sorafenib DC4B8MO Sorafenib Carcinoma (Cell Line: EFM192B) [4]
RTB101 + Sorafenib DCSDK7Q Sorafenib Carcinoma (Cell Line: MDAMB436) [4]
RTB101 + Sorafenib DCC1WXX Sorafenib Colon adenocarcinoma (Cell Line: LOVO) [4]
RTB101 + Sorafenib DC0LIV0 Sorafenib Colon carcinoma (Cell Line: RKO) [4]
RTB101 + Sorafenib DC8COYX Sorafenib Invasive ductal carcinoma (Cell Line: T-47D) [4]
RTB101 + Ruxolitinib DCQ7H9K Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [5]
RTB101 + Trametinib DCMVQXP Trametinib Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
RTB101 + Trametinib DCZXVQJ Trametinib Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
RTB101 + Trametinib DCZNA62 Trametinib Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
RTB101 + SCH-900776 DC2AJYS SCH-900776 Adenocarcinoma (Cell Line: OVCAR3) [5]
RTB101 + SCH-900776 DCAVLNZ SCH-900776 Adenocarcinoma (Cell Line: A427) [5]
RTB101 + SCH-900776 DCYMZHV SCH-900776 Adenocarcinoma (Cell Line: NCIH2122) [5]
RTB101 + SCH-900776 DCN0Q5D SCH-900776 Adenocarcinoma (Cell Line: NCIH23) [5]
RTB101 + SCH-900776 DCKA5NH SCH-900776 Adenocarcinoma (Cell Line: NCIH520) [5]
RTB101 + SCH-900776 DC2QPIS SCH-900776 Adenocarcinoma (Cell Line: COLO320DM) [5]
RTB101 + SCH-900776 DCFO2BC SCH-900776 Adenocarcinoma (Cell Line: HCT116) [5]
RTB101 + SCH-900776 DCDEWZD SCH-900776 Adenocarcinoma (Cell Line: HT29) [5]
RTB101 + SCH-900776 DCTFSEU SCH-900776 Amelanotic melanoma (Cell Line: A2058) [5]
RTB101 + SCH-900776 DCTMSTN SCH-900776 Germ cell tumour (Cell Line: PA1) [5]
RTB101 + SCH-900776 DCVONCU SCH-900776 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
RTB101 + SCH-900776 DCDOI0G SCH-900776 Malignant melanoma (Cell Line: A375) [5]
RTB101 + SCH-900776 DCY2RQO SCH-900776 Malignant melanoma (Cell Line: RPMI7951) [5]
RTB101 + SCH-900776 DCOS18K SCH-900776 Malignant melanoma (Cell Line: SKMEL30) [5]
RTB101 + SCH-900776 DC4331X SCH-900776 Malignant melanoma (Cell Line: UACC62) [5]
RTB101 + SCH-900776 DCYXLID SCH-900776 Mesothelioma (Cell Line: MSTO) [5]
RTB101 + SCH-900776 DCJJ5G0 SCH-900776 Non small cell carcinoma (Cell Line: SKMES1) [5]
RTB101 + SCH-900776 DCMI9TQ SCH-900776 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
RTB101 + SCH-900776 DCO053M SCH-900776 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
RTB101 + SCH-900776 DC8QJPQ SCH-900776 Prostate carcinoma (Cell Line: VCAP) [5]
RTB101 + 10-hydroxycamptothecin DCK4H65 10-hydroxycamptothecin Adenocarcinoma (Cell Line: CAOV3) [5]
RTB101 + 10-hydroxycamptothecin DCDER3M 10-hydroxycamptothecin Adenocarcinoma (Cell Line: A427) [5]
RTB101 + 10-hydroxycamptothecin DCU89D9 10-hydroxycamptothecin Adenocarcinoma (Cell Line: NCIH1650) [5]
RTB101 + 10-hydroxycamptothecin DCI5ZDI 10-hydroxycamptothecin Adenocarcinoma (Cell Line: NCIH2122) [5]
RTB101 + 10-hydroxycamptothecin DC61SB2 10-hydroxycamptothecin Adenocarcinoma (Cell Line: NCIH23) [5]
RTB101 + 10-hydroxycamptothecin DCNBLJJ 10-hydroxycamptothecin Adenocarcinoma (Cell Line: NCIH520) [5]
RTB101 + 10-hydroxycamptothecin DCJS2P9 10-hydroxycamptothecin Adenocarcinoma (Cell Line: COLO320DM) [5]
RTB101 + 10-hydroxycamptothecin DC195ZG 10-hydroxycamptothecin Adenocarcinoma (Cell Line: DLD1) [5]
RTB101 + 10-hydroxycamptothecin DC5FL23 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HCT116) [5]
RTB101 + 10-hydroxycamptothecin DC1TSGF 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HT29) [5]
RTB101 + 10-hydroxycamptothecin DC25U1I 10-hydroxycamptothecin Adenocarcinoma (Cell Line: SW-620) [5]
RTB101 + 10-hydroxycamptothecin DC0QG2Q 10-hydroxycamptothecin Germ cell tumour (Cell Line: PA1) [5]
RTB101 + 10-hydroxycamptothecin DCA4PKC 10-hydroxycamptothecin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
RTB101 + 10-hydroxycamptothecin DC73RMG 10-hydroxycamptothecin Malignant melanoma (Cell Line: A375) [5]
RTB101 + 10-hydroxycamptothecin DCGQTR9 10-hydroxycamptothecin Malignant melanoma (Cell Line: HT144) [5]
RTB101 + 10-hydroxycamptothecin DCBB4AQ 10-hydroxycamptothecin Malignant melanoma (Cell Line: SKMEL30) [5]
RTB101 + 10-hydroxycamptothecin DC4VG6Z 10-hydroxycamptothecin Malignant melanoma (Cell Line: UACC62) [5]
RTB101 + 10-hydroxycamptothecin DCVDE1Y 10-hydroxycamptothecin Malignant melanoma (Cell Line: RPMI7951) [5]
RTB101 + 10-hydroxycamptothecin DC78ZRE 10-hydroxycamptothecin Mesothelioma (Cell Line: MSTO) [5]
RTB101 + 10-hydroxycamptothecin DCBLW49 10-hydroxycamptothecin Non small cell carcinoma (Cell Line: SKMES1) [5]
RTB101 + 10-hydroxycamptothecin DCUHBEJ 10-hydroxycamptothecin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
RTB101 + 10-hydroxycamptothecin DCJGGBO 10-hydroxycamptothecin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
RTB101 + 10-hydroxycamptothecin DCQJMLK 10-hydroxycamptothecin Prostate carcinoma (Cell Line: LNCAP) [5]
RTB101 + 10-hydroxycamptothecin DCHJCX9 10-hydroxycamptothecin Prostate carcinoma (Cell Line: VCAP) [5]
RTB101 + Cotellic DCXJOW8 Cotellic Embryonal rhabdomyosarcoma (Cell Line: Rh36) [5]
RTB101 + Cotellic DCIK6JV Cotellic Embryonal rhabdomyosarcoma (Cell Line: CTR) [5]
RTB101 + Cotellic DC9B0VR Cotellic Embryonal rhabdomyosarcoma (Cell Line: RD) [5]
RTB101 + Ridaforolimus DCDAC43 Ridaforolimus Adenocarcinoma (Cell Line: CAOV3) [5]
RTB101 + Ridaforolimus DCWQ8GD Ridaforolimus Adenocarcinoma (Cell Line: OVCAR3) [5]
RTB101 + Ridaforolimus DCNN60Y Ridaforolimus Adenocarcinoma (Cell Line: A427) [5]
RTB101 + Ridaforolimus DC633J4 Ridaforolimus Adenocarcinoma (Cell Line: NCIH1650) [5]
RTB101 + Ridaforolimus DCK1RN6 Ridaforolimus Adenocarcinoma (Cell Line: NCIH2122) [5]
RTB101 + Ridaforolimus DC11JDJ Ridaforolimus Adenocarcinoma (Cell Line: NCIH23) [5]
RTB101 + Ridaforolimus DC2FP5T Ridaforolimus Adenocarcinoma (Cell Line: NCIH520) [5]
RTB101 + Ridaforolimus DCAAG7Z Ridaforolimus Adenocarcinoma (Cell Line: COLO320DM) [5]
RTB101 + Ridaforolimus DCYA1NH Ridaforolimus Adenocarcinoma (Cell Line: DLD1) [5]
RTB101 + Ridaforolimus DC1JPKC Ridaforolimus Adenocarcinoma (Cell Line: HT29) [5]
RTB101 + Ridaforolimus DCI3XU5 Ridaforolimus Adenocarcinoma (Cell Line: SW-620) [5]
RTB101 + Ridaforolimus DCVFEF2 Ridaforolimus Amelanotic melanoma (Cell Line: A2058) [5]
RTB101 + Ridaforolimus DC6B4WV Ridaforolimus Germ cell tumour (Cell Line: PA1) [5]
RTB101 + Ridaforolimus DCVYWZH Ridaforolimus Large cell lung carcinoma (Cell Line: NCI-H460) [5]
RTB101 + Ridaforolimus DCP24AP Ridaforolimus Malignant melanoma (Cell Line: A375) [5]
RTB101 + Ridaforolimus DCWP25P Ridaforolimus Malignant melanoma (Cell Line: HT144) [5]
RTB101 + Ridaforolimus DC7KTTZ Ridaforolimus Malignant melanoma (Cell Line: RPMI7951) [5]
RTB101 + Ridaforolimus DCJH8R6 Ridaforolimus Malignant melanoma (Cell Line: SKMEL30) [5]
RTB101 + Ridaforolimus DCGTM6F Ridaforolimus Malignant melanoma (Cell Line: UACC62) [5]
RTB101 + Ridaforolimus DCPKBCI Ridaforolimus Mesothelioma (Cell Line: MSTO) [5]
RTB101 + Ridaforolimus DCH0RMP Ridaforolimus Non small cell carcinoma (Cell Line: SKMES1) [5]
RTB101 + Ridaforolimus DC6P8BI Ridaforolimus Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
RTB101 + Ridaforolimus DCUA4QR Ridaforolimus Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
RTB101 + Ridaforolimus DC1AMWS Ridaforolimus Prostate carcinoma (Cell Line: VCAP) [5]
RTB101 + Ridaforolimus DCD3KOO Ridaforolimus Prostate carcinoma (Cell Line: LNCAP) [5]
RTB101 + Lomustine DCUVNIS Lomustine Adenocarcinoma (Cell Line: CAOV3) [5]
RTB101 + Lomustine DCJBKUL Lomustine Adenocarcinoma (Cell Line: A427) [5]
RTB101 + Lomustine DCBGLHP Lomustine Adenocarcinoma (Cell Line: NCIH2122) [5]
RTB101 + Lomustine DC2GJI8 Lomustine Adenocarcinoma (Cell Line: NCIH520) [5]
RTB101 + Lomustine DC94XDY Lomustine Adenocarcinoma (Cell Line: COLO320DM) [5]
RTB101 + Lomustine DCB2JM4 Lomustine Adenocarcinoma (Cell Line: DLD1) [5]
RTB101 + Lomustine DCYJRRX Lomustine Adenocarcinoma (Cell Line: HCT116) [5]
RTB101 + Lomustine DCRYRK1 Lomustine Adenocarcinoma (Cell Line: HT29) [5]
RTB101 + Lomustine DCYYCYP Lomustine Amelanotic melanoma (Cell Line: A2058) [5]
RTB101 + Lomustine DCRT4O2 Lomustine Malignant melanoma (Cell Line: A375) [5]
RTB101 + Lomustine DCVXHTC Lomustine Malignant melanoma (Cell Line: RPMI7951) [5]
RTB101 + Lomustine DCOY5B0 Lomustine Malignant melanoma (Cell Line: SKMEL30) [5]
RTB101 + Lomustine DCYT66Q Lomustine Malignant melanoma (Cell Line: UACC62) [5]
RTB101 + Lomustine DCFN2Z9 Lomustine Mesothelioma (Cell Line: MSTO) [5]
RTB101 + Lomustine DCJSEFX Lomustine Non small cell carcinoma (Cell Line: SKMES1) [5]
RTB101 + Lomustine DC3NJT4 Lomustine Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
RTB101 + Lomustine DCEWYXO Lomustine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
RTB101 + Lomustine DC4UA5G Lomustine Prostate carcinoma (Cell Line: VCAP) [5]
RTB101 + Sorafenib DCWH8ZQ Sorafenib Adenocarcinoma (Cell Line: CAOV3) [5]
RTB101 + Sorafenib DC16IMQ Sorafenib Adenocarcinoma (Cell Line: A427) [5]
RTB101 + Sorafenib DCAMME7 Sorafenib Adenocarcinoma (Cell Line: NCIH23) [5]
RTB101 + Sorafenib DCER6YV Sorafenib Adenocarcinoma (Cell Line: NCIH520) [5]
RTB101 + Sorafenib DCBMABY Sorafenib Adenocarcinoma (Cell Line: COLO320DM) [5]
RTB101 + Sorafenib DCGOKWW Sorafenib Adenocarcinoma (Cell Line: DLD1) [5]
RTB101 + Sorafenib DCY5M0B Sorafenib Adenocarcinoma (Cell Line: HT29) [5]
RTB101 + Sorafenib DCV8R3T Sorafenib Adenocarcinoma (Cell Line: SW-620) [5]
RTB101 + Sorafenib DCI0JA3 Sorafenib Adenocarcinoma (Cell Line: HCT116) [5]
RTB101 + Sorafenib DCD1WE6 Sorafenib Amelanotic melanoma (Cell Line: A2058) [5]
RTB101 + Sorafenib DCFDGW8 Sorafenib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
RTB101 + Sorafenib DCUAEPT Sorafenib Malignant melanoma (Cell Line: A375) [5]
RTB101 + Sorafenib DC9E420 Sorafenib Malignant melanoma (Cell Line: HT144) [5]
RTB101 + Sorafenib DCBHBJQ Sorafenib Malignant melanoma (Cell Line: SKMEL30) [5]
RTB101 + Sorafenib DCH921X Sorafenib Malignant melanoma (Cell Line: UACC62) [5]
RTB101 + Sorafenib DC9MEAQ Sorafenib Mesothelioma (Cell Line: MSTO) [5]
RTB101 + Sorafenib DCD4HXN Sorafenib Non small cell carcinoma (Cell Line: SKMES1) [5]
RTB101 + Sorafenib DCMG216 Sorafenib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
RTB101 + Sorafenib DCRLTY9 Sorafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
RTB101 + Sorafenib DCELGF6 Sorafenib Prostate carcinoma (Cell Line: LNCAP) [5]
RTB101 + Sorafenib DCD077A Sorafenib Prostate carcinoma (Cell Line: VCAP) [5]
SCH 727965 + RTB101 DCVRVAO SCH 727965 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
SCH 727965 + RTB101 DC6OAUB SCH 727965 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
SCH 727965 + RTB101 DC9YP2G SCH 727965 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
SCH 727965 + RTB101 DC932MB SCH 727965 Breast carcinoma (Cell Line: KPL1) [4]
SCH 727965 + RTB101 DCE2309 SCH 727965 Breast carcinoma (Cell Line: OCUBM) [4]
SCH 727965 + RTB101 DCZPD8J SCH 727965 Carcinoma (Cell Line: EFM192B) [4]
SCH 727965 + RTB101 DCUI5MH SCH 727965 Carcinoma (Cell Line: MDAMB436) [4]
SCH 727965 + RTB101 DC1G1GT SCH 727965 Colon adenocarcinoma (Cell Line: LOVO) [4]
SCH 727965 + RTB101 DCFWUUJ SCH 727965 Colon carcinoma (Cell Line: RKO) [4]
SCH 727965 + RTB101 DCIYXJ2 SCH 727965 Rectal adenocarcinoma (Cell Line: SW837) [4]
SCH 727965 + RTB101 DCZPUJP SCH 727965 Adenocarcinoma (Cell Line: CAOV3) [5]
SCH 727965 + RTB101 DCG8JG3 SCH 727965 Adenocarcinoma (Cell Line: A427) [5]
SCH 727965 + RTB101 DCQGR5Z SCH 727965 Adenocarcinoma (Cell Line: NCIH1650) [5]
SCH 727965 + RTB101 DCKTMAI SCH 727965 Adenocarcinoma (Cell Line: NCIH23) [5]
SCH 727965 + RTB101 DCKTV40 SCH 727965 Adenocarcinoma (Cell Line: NCIH520) [5]
SCH 727965 + RTB101 DCO4K1X SCH 727965 Adenocarcinoma (Cell Line: COLO320DM) [5]
SCH 727965 + RTB101 DCN0FCN SCH 727965 Adenocarcinoma (Cell Line: DLD1) [5]
SCH 727965 + RTB101 DCTTJO9 SCH 727965 Adenocarcinoma (Cell Line: HCT116) [5]
SCH 727965 + RTB101 DCFPIIA SCH 727965 Adenocarcinoma (Cell Line: HT29) [5]
SCH 727965 + RTB101 DCEGMN5 SCH 727965 Adenocarcinoma (Cell Line: SW-620) [5]
SCH 727965 + RTB101 DCWCVOI SCH 727965 Amelanotic melanoma (Cell Line: A2058) [5]
SCH 727965 + RTB101 DCHBUCT SCH 727965 Germ cell tumour (Cell Line: PA1) [5]
SCH 727965 + RTB101 DCI057A SCH 727965 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
SCH 727965 + RTB101 DC38Q9O SCH 727965 Malignant melanoma (Cell Line: A375) [5]
SCH 727965 + RTB101 DCZ590L SCH 727965 Malignant melanoma (Cell Line: HT144) [5]
SCH 727965 + RTB101 DCLY1M6 SCH 727965 Malignant melanoma (Cell Line: RPMI7951) [5]
SCH 727965 + RTB101 DCBBX9G SCH 727965 Malignant melanoma (Cell Line: SKMEL30) [5]
SCH 727965 + RTB101 DCHBIG2 SCH 727965 Malignant melanoma (Cell Line: UACC62) [5]
SCH 727965 + RTB101 DCDAWN4 SCH 727965 Mesothelioma (Cell Line: MSTO) [5]
SCH 727965 + RTB101 DCB2QR9 SCH 727965 Non small cell carcinoma (Cell Line: SKMES1) [5]
SCH 727965 + RTB101 DCYZG6H SCH 727965 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
SCH 727965 + RTB101 DCNHMMU SCH 727965 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
SCH 727965 + RTB101 DCH3S9D SCH 727965 Prostate carcinoma (Cell Line: LNCAP) [5]
SCH 727965 + RTB101 DCRSEZH SCH 727965 Prostate carcinoma (Cell Line: VCAP) [5]
SNX-2112 + RTB101 DC24OZ1 SNX-2112 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
SNX-2112 + RTB101 DC3JG56 SNX-2112 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
SNX-2112 + RTB101 DC2RGU3 SNX-2112 Breast carcinoma (Cell Line: OCUBM) [4]
SNX-2112 + RTB101 DC801JN SNX-2112 Carcinoma (Cell Line: OV90) [4]
SNX-2112 + RTB101 DCCLDRK SNX-2112 Carcinoma (Cell Line: MDAMB436) [4]
SNX-2112 + RTB101 DCQFSS3 SNX-2112 Colon adenocarcinoma (Cell Line: LOVO) [4]
SNX-2112 + RTB101 DCCQX5B SNX-2112 Colon carcinoma (Cell Line: RKO) [4]
SNX-2112 + RTB101 DC0FJPG SNX-2112 Invasive ductal carcinoma (Cell Line: T-47D) [4]
SNX-2112 + RTB101 DC4TXJD SNX-2112 Rectal adenocarcinoma (Cell Line: SW837) [4]
SNX-2112 + RTB101 DCLUOV9 SNX-2112 Adenocarcinoma (Cell Line: CAOV3) [5]
SNX-2112 + RTB101 DCO48A5 SNX-2112 Adenocarcinoma (Cell Line: A427) [5]
SNX-2112 + RTB101 DCKUWNC SNX-2112 Adenocarcinoma (Cell Line: NCIH1650) [5]
SNX-2112 + RTB101 DCHYKY9 SNX-2112 Adenocarcinoma (Cell Line: NCIH2122) [5]
SNX-2112 + RTB101 DCKCJYE SNX-2112 Adenocarcinoma (Cell Line: NCIH520) [5]
SNX-2112 + RTB101 DCA1EJW SNX-2112 Adenocarcinoma (Cell Line: DLD1) [5]
SNX-2112 + RTB101 DCBBXWJ SNX-2112 Adenocarcinoma (Cell Line: HCT116) [5]
SNX-2112 + RTB101 DC5D886 SNX-2112 Adenocarcinoma (Cell Line: HT29) [5]
SNX-2112 + RTB101 DC7KLTO SNX-2112 Adenocarcinoma (Cell Line: SW-620) [5]
SNX-2112 + RTB101 DC0OURA SNX-2112 Amelanotic melanoma (Cell Line: A2058) [5]
SNX-2112 + RTB101 DCXS1QQ SNX-2112 Germ cell tumour (Cell Line: PA1) [5]
SNX-2112 + RTB101 DCQ0USO SNX-2112 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
SNX-2112 + RTB101 DCPHVNA SNX-2112 Malignant melanoma (Cell Line: A375) [5]
SNX-2112 + RTB101 DCNOMJ4 SNX-2112 Malignant melanoma (Cell Line: HT144) [5]
SNX-2112 + RTB101 DCBJX51 SNX-2112 Malignant melanoma (Cell Line: RPMI7951) [5]
SNX-2112 + RTB101 DC7881Q SNX-2112 Malignant melanoma (Cell Line: SKMEL30) [5]
SNX-2112 + RTB101 DC65VHH SNX-2112 Malignant melanoma (Cell Line: UACC62) [5]
SNX-2112 + RTB101 DCASNR4 SNX-2112 Mesothelioma (Cell Line: MSTO) [5]
SNX-2112 + RTB101 DCER53Z SNX-2112 Non small cell carcinoma (Cell Line: SKMES1) [5]
SNX-2112 + RTB101 DCEC3K1 SNX-2112 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
SNX-2112 + RTB101 DC9HIBF SNX-2112 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
SNX-2112 + RTB101 DCMSZZQ SNX-2112 Prostate carcinoma (Cell Line: LNCAP) [5]
Taxol + RTB101 DCVRHE9 Taxol Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Taxol + RTB101 DC0T5VG Taxol Breast carcinoma (Cell Line: OCUBM) [4]
Taxol + RTB101 DC3CIWF Taxol Colon carcinoma (Cell Line: RKO) [4]
Taxol + RTB101 DCDNK38 Taxol Invasive ductal carcinoma (Cell Line: T-47D) [4]
Taxol + RTB101 DCTRQ30 Taxol Rectal adenocarcinoma (Cell Line: SW837) [4]
Taxol + RTB101 DCS7NMJ Taxol Adenocarcinoma (Cell Line: NCIH520) [5]
Taxol + RTB101 DC92RGN Taxol Adenocarcinoma (Cell Line: COLO320DM) [5]
Taxol + RTB101 DCZV5KI Taxol Adenocarcinoma (Cell Line: DLD1) [5]
Taxol + RTB101 DCGRRQS Taxol Adenocarcinoma (Cell Line: SW-620) [5]
Taxol + RTB101 DCBBQ4W Taxol Amelanotic melanoma (Cell Line: A2058) [5]
Taxol + RTB101 DCTTLOL Taxol Germ cell tumour (Cell Line: PA1) [5]
Taxol + RTB101 DCZSP5I Taxol Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Taxol + RTB101 DCZNR2C Taxol Malignant melanoma (Cell Line: A375) [5]
Taxol + RTB101 DCH19U1 Taxol Malignant melanoma (Cell Line: HT144) [5]
Taxol + RTB101 DCZ9I0Z Taxol Malignant melanoma (Cell Line: RPMI7951) [5]
Taxol + RTB101 DCR11MQ Taxol Malignant melanoma (Cell Line: SKMEL30) [5]
Taxol + RTB101 DCFL9U6 Taxol Mesothelioma (Cell Line: MSTO) [5]
Taxol + RTB101 DCFKD6E Taxol Non small cell carcinoma (Cell Line: SKMES1) [5]
Taxol + RTB101 DCB4T7D Taxol Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Taxol + RTB101 DC2GCV1 Taxol Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Topotecan + RTB101 DC5COY2 Topotecan Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Topotecan + RTB101 DC4UEBS Topotecan Breast carcinoma (Cell Line: OCUBM) [4]
Topotecan + RTB101 DCAF5LU Topotecan Carcinoma (Cell Line: EFM192B) [4]
Topotecan + RTB101 DCGVQFA Topotecan Invasive ductal carcinoma (Cell Line: T-47D) [4]
Topotecan + RTB101 DCU7Y3I Topotecan Adenocarcinoma (Cell Line: A427) [5]
Topotecan + RTB101 DCIEMLA Topotecan Adenocarcinoma (Cell Line: NCIH1650) [5]
Topotecan + RTB101 DCJI2P2 Topotecan Adenocarcinoma (Cell Line: NCIH2122) [5]
Topotecan + RTB101 DCQH0CC Topotecan Adenocarcinoma (Cell Line: NCIH520) [5]
Topotecan + RTB101 DCWCK25 Topotecan Adenocarcinoma (Cell Line: COLO320DM) [5]
Topotecan + RTB101 DC79END Topotecan Adenocarcinoma (Cell Line: DLD1) [5]
Topotecan + RTB101 DCLKIEL Topotecan Adenocarcinoma (Cell Line: HT29) [5]
Topotecan + RTB101 DCBXQ1R Topotecan Adenocarcinoma (Cell Line: SW-620) [5]
Topotecan + RTB101 DC2OV98 Topotecan Amelanotic melanoma (Cell Line: A2058) [5]
Topotecan + RTB101 DC6FRQK Topotecan Germ cell tumour (Cell Line: PA1) [5]
Topotecan + RTB101 DC9E021 Topotecan Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Topotecan + RTB101 DCXRFYS Topotecan Malignant melanoma (Cell Line: A375) [5]
Topotecan + RTB101 DCYINVY Topotecan Malignant melanoma (Cell Line: HT144) [5]
Topotecan + RTB101 DCON7DV Topotecan Malignant melanoma (Cell Line: RPMI7951) [5]
Topotecan + RTB101 DC9A2G5 Topotecan Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Topotecan + RTB101 DCG7LEP Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Topotecan + RTB101 DCF9BZL Topotecan Prostate carcinoma (Cell Line: LNCAP) [5]
Trametinib + RTB101 DCHZOKA Trametinib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [5]
Vinblastine + RTB101 DCD8YOI Vinblastine Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinblastine + RTB101 DCQRQA1 Vinblastine Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + RTB101 DCR2765 Vinblastine Adenocarcinoma (Cell Line: NCIH23) [3]
Vinblastine + RTB101 DCQV4EK Vinblastine Adenocarcinoma (Cell Line: NCIH520) [3]
Vinblastine + RTB101 DCBH7TJ Vinblastine Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + RTB101 DCT44EB Vinblastine Adenocarcinoma (Cell Line: DLD1) [3]
Vinblastine + RTB101 DCMB3IC Vinblastine Adenocarcinoma (Cell Line: HCT116) [3]
Vinblastine + RTB101 DCWR7S4 Vinblastine Adenocarcinoma (Cell Line: HT29) [3]
Vinblastine + RTB101 DCVRXHH Vinblastine Adenocarcinoma (Cell Line: SW-620) [3]
Vinblastine + RTB101 DCI8MJV Vinblastine Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + RTB101 DCPJJL0 Vinblastine Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + RTB101 DCQ9HSO Vinblastine Germ cell tumour (Cell Line: PA1) [3]
Vinblastine + RTB101 DCB9VNT Vinblastine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinblastine + RTB101 DCZTZQK Vinblastine Malignant melanoma (Cell Line: A375) [3]
Vinblastine + RTB101 DC7870Q Vinblastine Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + RTB101 DCO8ZXF Vinblastine Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + RTB101 DC9RKB6 Vinblastine Malignant melanoma (Cell Line: SKMEL30) [3]
Vinblastine + RTB101 DCY9CUR Vinblastine Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + RTB101 DCLG3CI Vinblastine Non small cell carcinoma (Cell Line: SKMES1) [3]
Vinblastine + RTB101 DCE8GXP Vinblastine Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + RTB101 DCLR091 Vinblastine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + RTB101 DCAVNIA Vinblastine Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + RTB101 DCU29SX Vinblastine Prostate carcinoma (Cell Line: LNCAP) [3]
Vinblastine + RTB101 DCQ722F Vinblastine Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Vinblastine + RTB101 DCOPZRY Vinblastine Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Vinblastine + RTB101 DCLP3K7 Vinblastine Breast carcinoma (Cell Line: KPL1) [4]
Vinblastine + RTB101 DCPLECM Vinblastine Breast carcinoma (Cell Line: OCUBM) [4]
Vinblastine + RTB101 DCWRZ2J Vinblastine Carcinoma (Cell Line: OV90) [4]
Vinblastine + RTB101 DCO8N3E Vinblastine Carcinoma (Cell Line: EFM192B) [4]
Vinblastine + RTB101 DC2612B Vinblastine Carcinoma (Cell Line: MDAMB436) [4]
Vinblastine + RTB101 DCY95L2 Vinblastine Colon carcinoma (Cell Line: RKO) [4]
Vinblastine + RTB101 DCY9A9C Vinblastine Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vinblastine + RTB101 DCEMH7E Vinblastine Rectal adenocarcinoma (Cell Line: SW837) [4]
Vinorelbine + RTB101 DCF0T30 Vinorelbine Breast and ovarian cancer syndrome (Cell Line: UWB1289) [4]
Vinorelbine + RTB101 DC7UU2U Vinorelbine Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Vinorelbine + RTB101 DC65TFK Vinorelbine Breast carcinoma (Cell Line: ZR751) [4]
Vinorelbine + RTB101 DCFHG4M Vinorelbine Breast carcinoma (Cell Line: KPL1) [4]
Vinorelbine + RTB101 DCYLZLX Vinorelbine Breast carcinoma (Cell Line: OCUBM) [4]
Vinorelbine + RTB101 DCL8TSS Vinorelbine Carcinoma (Cell Line: OV90) [4]
Vinorelbine + RTB101 DC113KU Vinorelbine Carcinoma (Cell Line: EFM192B) [4]
Vinorelbine + RTB101 DCIT7OA Vinorelbine Carcinoma (Cell Line: MDAMB436) [4]
Vinorelbine + RTB101 DCI9FN5 Vinorelbine Colon carcinoma (Cell Line: RKO) [4]
Vinorelbine + RTB101 DCSEJ9R Vinorelbine Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vinorelbine + RTB101 DCYISEV Vinorelbine Rectal adenocarcinoma (Cell Line: SW837) [4]
Vinorelbine + RTB101 DCZEDNJ Vinorelbine Adenocarcinoma (Cell Line: OVCAR3) [5]
Vinorelbine + RTB101 DCXYZPH Vinorelbine Adenocarcinoma (Cell Line: NCIH2122) [5]
Vinorelbine + RTB101 DCCBYMY Vinorelbine Adenocarcinoma (Cell Line: NCIH520) [5]
Vinorelbine + RTB101 DCXON7B Vinorelbine Adenocarcinoma (Cell Line: COLO320DM) [5]
Vinorelbine + RTB101 DC24MQE Vinorelbine Adenocarcinoma (Cell Line: DLD1) [5]
Vinorelbine + RTB101 DC7SC5X Vinorelbine Adenocarcinoma (Cell Line: HCT116) [5]
Vinorelbine + RTB101 DCXG6YT Vinorelbine Adenocarcinoma (Cell Line: HT29) [5]
Vinorelbine + RTB101 DCH8HUZ Vinorelbine Adenocarcinoma (Cell Line: SW-620) [5]
Vinorelbine + RTB101 DCEKEVB Vinorelbine Amelanotic melanoma (Cell Line: A2058) [5]
Vinorelbine + RTB101 DC5HM33 Vinorelbine Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [5]
Vinorelbine + RTB101 DCAX45X Vinorelbine Germ cell tumour (Cell Line: PA1) [5]
Vinorelbine + RTB101 DCB8YDX Vinorelbine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vinorelbine + RTB101 DC4YWJ8 Vinorelbine Malignant melanoma (Cell Line: A375) [5]
Vinorelbine + RTB101 DCNUY14 Vinorelbine Malignant melanoma (Cell Line: HT144) [5]
Vinorelbine + RTB101 DC90Q7F Vinorelbine Malignant melanoma (Cell Line: RPMI7951) [5]
Vinorelbine + RTB101 DCWW5WO Vinorelbine Malignant melanoma (Cell Line: SKMEL30) [5]
Vinorelbine + RTB101 DCZ9ZAQ Vinorelbine Malignant melanoma (Cell Line: UACC62) [5]
Vinorelbine + RTB101 DCPHLQ0 Vinorelbine Mesothelioma (Cell Line: MSTO) [5]
Vinorelbine + RTB101 DCX16J7 Vinorelbine Non small cell carcinoma (Cell Line: SKMES1) [5]
Vinorelbine + RTB101 DCL3MY4 Vinorelbine Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [5]
Vinorelbine + RTB101 DC9WI8S Vinorelbine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Vinorelbine + RTB101 DCFAH69 Vinorelbine Prostate carcinoma (Cell Line: LNCAP) [5]
Vorinostat + RTB101 DCUDC1L Vorinostat Adenocarcinoma (Cell Line: CAOV3) [3]
Vorinostat + RTB101 DCHH9I7 Vorinostat Adenocarcinoma (Cell Line: A427) [3]
Vorinostat + RTB101 DCLS7CU Vorinostat Adenocarcinoma (Cell Line: NCIH1650) [3]
Vorinostat + RTB101 DCZJ68N Vorinostat Adenocarcinoma (Cell Line: NCIH2122) [3]
Vorinostat + RTB101 DCIXRI1 Vorinostat Adenocarcinoma (Cell Line: NCIH23) [3]
Vorinostat + RTB101 DCSYHTX Vorinostat Adenocarcinoma (Cell Line: NCIH520) [3]
Vorinostat + RTB101 DCSL0RP Vorinostat Adenocarcinoma (Cell Line: COLO320DM) [3]
Vorinostat + RTB101 DC7Y2WT Vorinostat Adenocarcinoma (Cell Line: DLD1) [3]
Vorinostat + RTB101 DCFUPTT Vorinostat Adenocarcinoma (Cell Line: HCT116) [3]
Vorinostat + RTB101 DC555F6 Vorinostat Adenocarcinoma (Cell Line: HT29) [3]
Vorinostat + RTB101 DCAKTPQ Vorinostat Adenocarcinoma (Cell Line: SW-620) [3]
Vorinostat + RTB101 DCR2YJN Vorinostat Amelanotic melanoma (Cell Line: A2058) [3]
Vorinostat + RTB101 DCSI83N Vorinostat Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vorinostat + RTB101 DCIP34M Vorinostat Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vorinostat + RTB101 DCYZC05 Vorinostat Malignant melanoma (Cell Line: A375) [3]
Vorinostat + RTB101 DCOJD80 Vorinostat Malignant melanoma (Cell Line: HT144) [3]
Vorinostat + RTB101 DCNVPAF Vorinostat Malignant melanoma (Cell Line: RPMI7951) [3]
Vorinostat + RTB101 DC7ORZ4 Vorinostat Malignant melanoma (Cell Line: SKMEL30) [3]
Vorinostat + RTB101 DCT11NZ Vorinostat Malignant melanoma (Cell Line: UACC62) [3]
Vorinostat + RTB101 DC1TKK3 Vorinostat Mesothelioma (Cell Line: MSTO) [3]
Vorinostat + RTB101 DCIYBHD Vorinostat Non small cell carcinoma (Cell Line: SKMES1) [3]
Vorinostat + RTB101 DCN1W7B Vorinostat Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vorinostat + RTB101 DC1FXLW Vorinostat Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vorinostat + RTB101 DCUPU3O Vorinostat Prostate carcinoma (Cell Line: LNCAP) [3]
Vorinostat + RTB101 DCVDV78 Vorinostat Prostate carcinoma (Cell Line: VCAP) [3]
Vorinostat + RTB101 DC0MVM5 Vorinostat Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [4]
Vorinostat + RTB101 DC00MOZ Vorinostat Breast carcinoma (Cell Line: KPL1) [4]
Vorinostat + RTB101 DC4UG94 Vorinostat Carcinoma (Cell Line: EFM192B) [4]
Vorinostat + RTB101 DCJ73XG Vorinostat Colon carcinoma (Cell Line: RKO) [4]
Vorinostat + RTB101 DCC6D78 Vorinostat Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vorinostat + RTB101 DCBTML2 Vorinostat Rectal adenocarcinoma (Cell Line: SW837) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 947 DrugCom(s)
2 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
RTB101 + Letrozole DC9YJI0 Letrozole Metastatic Breast Cancer [6]
RTB101 + Everolimus DCQOP4C Everolimus Cancer [7]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04139915) Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT04409327) Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes. U.S. National Institutes of Health.
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
6 ClinicalTrials.gov (NCT01248494) PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
7 ClinicalTrials.gov (NCT01508104) Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors